Disease,Number,Sponsor,Date,Phase,Study Type,URL
Kidney Cancer,NCT02143492,Argos Therapeutics,August 2013,None,Observational,https://clinicaltrials.gov/show/NCT02143492
T-cell Lymphoma,NCT02846935,Yogen Saunthararajah,"April 25, 2017",Early Phase 1,Interventional,https://clinicaltrials.gov/show/NCT02846935
Uveal Melanoma,NCT02849145,Institut Curie,September 2014,N/A,Interventional,https://clinicaltrials.gov/show/NCT02849145
Uveal Melanoma,NCT02843386,Institut Curie,"June 23, 2009",Phase 3,Interventional,https://clinicaltrials.gov/show/NCT02843386
Cholangiocarcinoma,NCT03473574,AIO-Studien-gGmbH,"May 2, 2018",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03473574
Ureteral Cancer,NCT03474107,"Astellas Pharma Global Development, Inc.","June 27, 2018",Phase 3,Interventional,https://clinicaltrials.gov/show/NCT03474107
Kidney Cancer,NCT00176501,"Rutgers, The State University of New Jersey",August 2004,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00176501
Male Breast Cancer,NCT01153672,University of Washington,November 2010,N/A,Interventional,https://clinicaltrials.gov/show/NCT01153672
Cholangiocarcinoma,NCT01151761,Stanford University,January 2011,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01151761
Pheochromocytoma,NCT01152827,Seoul National University Hospital,July 2008,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01152827
Adenoid Cystic Carcinoma,NCT01152840,Seoul National University Hospital,July 2008,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01152840
Adrenocortical Carcinoma,NCT03723941,Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia,"July 1, 2018",Phase 3,Interventional,https://clinicaltrials.gov/show/NCT03723941
T-cell Lymphoma,NCT01941680,University Hospital Center of Martinique,"October 31, 2013",None,Observational,https://clinicaltrials.gov/show/NCT01941680
Pheochromocytoma,NCT01949714,University of Aarhus,August 2013,None,Observational,https://clinicaltrials.gov/show/NCT01949714
Hodgkin Lymphoma,NCT00722865,Massachusetts General Hospital,September 2008,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00722865
Primary Myelofibrosis,NCT00722254,University of Utah,June 2006,None,Observational,https://clinicaltrials.gov/show/NCT00722254
Fallopian Tube Cancer,NCT01137071,Recepta Biopharma,April 2011,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01137071
Cutaneous T Cell Lymphoma,NCT01132989,Florida Academic Dermatology Centers,May 2010,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01132989
Penile Cancer,NCT02817958,UNICANCER,April 2016,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02817958
Kidney Cancer,NCT04005820,Assistance Publique Hopitaux De Marseille,"August 1, 2019",N/A,Interventional,https://clinicaltrials.gov/show/NCT04005820
Fallopian Tube Cancer,NCT02948426,National Cancer Institute (NCI),"February 8, 2017",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT02948426
Thymoma,NCT02948855,Tianjin Medical University Cancer Institute and Hospital,October 2016,None,Observational,https://clinicaltrials.gov/show/NCT02948855
Adenoid Cystic Carcinoma,NCT02942693,Shanghai Proton and Heavy Ion Center,November 2016,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02942693
Adrenocortical Carcinoma,NCT00445718,Children's Oncology Group,July 2001,None,Observational,https://clinicaltrials.gov/show/NCT00445718
Kidney Cancer,NCT00445757,Case Comprehensive Cancer Center,January 2007,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00445757
Kaposi's Sarcoma,NCT00444379,"University of California, San Francisco",April 2007,Phase 4,Interventional,https://clinicaltrials.gov/show/NCT00444379
Leiomyosarcoma,NCT00282087,Sarcoma Alliance for Research through Collaboration,January 2006,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00282087
Kaposi's Sarcoma,NCT00287495,National Cancer Institute (NCI),"February 2, 2006",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00287495
Fallopian Tube Cancer,NCT00287859,"Masonic Cancer Center, University of Minnesota",August 2004,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00287859
Kidney Cancer,NCT00289146,Emory University,November 2005,None,Observational,https://clinicaltrials.gov/show/NCT00289146
Hodgkin Lymphoma,NCT02300402,The Lymphoma Academic Research Organisation,October 2014,None,Observational,https://clinicaltrials.gov/show/NCT02300402
T-cell Lymphoma,NCT02309580,Memorial Sloan Kettering Cancer Center,January 2015,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT02309580
Uveal Melanoma,NCT03052127,Aura Biosciences,"February 27, 2017",Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03052127
Waldenstr√∂m's Macroglobulinemia,NCT03053440,BeiGene,"January 25, 2017",Phase 3,Interventional,https://clinicaltrials.gov/show/NCT03053440
Adrenocortical Carcinoma,NCT04318730,West China Hospital,"April 1, 2020",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04318730
Kidney Cancer,NCT00626509,Gruppo Italiano Carcinoma Renale,February 2008,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00626509
Pheochromocytoma,NCT04557072,Jagiellonian University,"August 1, 2020",None,Observational,https://clinicaltrials.gov/show/NCT04557072
Pancreatic Neuroendocrine Tumor,NCT04134832,"University Hospital, Strasbourg, France","June 27, 2019",None,Observational,https://clinicaltrials.gov/show/NCT04134832
Mesothelioma,NCT01950572,National Cancer Institute (NCI),"September 9, 2013",None,Observational,https://clinicaltrials.gov/show/NCT01950572
Hodgkin Lymphoma,NCT01950364,"Millennium Pharmaceuticals, Inc.",November 2013,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT01950364
Uveal Melanoma,NCT01955941,OHSU Knight Cancer Institute,October 2013,None,Observational,https://clinicaltrials.gov/show/NCT01955941
Cholangiocarcinoma,NCT02456714,Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA),"May 31, 2016",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02456714
Hodgkin Lymphoma,NCT02453594,Merck Sharp & Dohme Corp.,"June 10, 2015",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02453594
Cholangiocarcinoma,NCT02452970,"EpicentRx, Inc.","July 16, 2015",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02452970
Pleuropulmonary Blastoma,NCT02452554,Children's Oncology Group,"October 12, 2015",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02452554
Primary Myelofibrosis,NCT03165734,CTI BioPharma,"June 26, 2017",Phase 3,Interventional,https://clinicaltrials.gov/show/NCT03165734
Cholangiocarcinoma,NCT03166436,Institute for Clinical and Experimental Medicine,"June 8, 2017",N/A,Interventional,https://clinicaltrials.gov/show/NCT03166436
Pheochromocytoma,NCT03160274,The University of Texas Health Science Center at San Antonio,"October 19, 2005",None,Observational [Patient Registry],https://clinicaltrials.gov/show/NCT03160274
Thymoma,NCT03078699,Third Military Medical University,"January 1, 2005",N/A,Interventional,https://clinicaltrials.gov/show/NCT03078699
Mesothelioma,NCT03075527,Dana-Farber Cancer Institute,"April 10, 2017",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03075527
Cholangiocarcinoma,NCT03079427,Asan Medical Center,"May 15, 2017",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03079427
Uveal Melanoma,NCT03070392,Immunocore Ltd,"October 16, 2017",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03070392
Thymoma,NCT03076554,National Cancer Institute (NCI),"April 19, 2017",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03076554
Mucosal Melanoma,NCT01166126,National Cancer Institute (NCI),October 2010,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01166126
Kidney Cancer,NCT01164228,Eastern Cooperative Oncology Group,"June 17, 2010",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01164228
Fallopian Tube Cancer,NCT01166737,AGO Study Group,July 2010,N/A,Interventional,https://clinicaltrials.gov/show/NCT01166737
Hodgkin Lymphoma,NCT01165645,Mayo Clinic,November 2010,N/A,Interventional,https://clinicaltrials.gov/show/NCT01165645
Hodgkin Lymphoma,NCT01652261,European Organisation for Research and Treatment of Cancer - EORTC,May 2013,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT01652261
Hodgkin Lymphoma,NCT01657331,Columbia University,July 2012,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01657331
Male Breast Cancer,NCT00089362,National Cancer Institute (NCI),July 2004,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00089362
Kidney Cancer,NCT00088803,Children's Oncology Group,August 2004,None,Observational,https://clinicaltrials.gov/show/NCT00088803
Kidney Cancer,NCT00080977,Blumenthal Cancer Center at Carolinas Medical Center,June 1998,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00080977
Fallopian Tube Cancer,NCT00085384,M.D. Anderson Cancer Center,July 2002,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00085384
Kidney Cancer,NCT00085436,Dartmouth-Hitchcock Medical Center,December 2003,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00085436
Kidney Cancer,NCT00082914,National Cancer Institute (NCI),March 2004,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00082914
Fallopian Tube Cancer,NCT00086567,National Cancer Institute (NCI),"December 12, 2005",None,Observational,https://clinicaltrials.gov/show/NCT00086567
Kidney Cancer,NCT00089102,Medical University of South Carolina,September 2003,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00089102
Kidney Cancer,NCT00087022,Wilex,July 2004,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00087022
Kidney Cancer,NCT00089778,National Cancer Institute (NCI),"September 10, 2004",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00089778
Kidney Cancer,NCT00080873,Children's Oncology Group,April 2004,N/A,Interventional,https://clinicaltrials.gov/show/NCT00080873
Kidney Cancer,NCT00416871,Centre Leon Berard,None,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00416871
Kidney Cancer,NCT00416429,Centre Leon Berard,None,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00416429
Leiomyosarcoma,NCT00414076,M.D. Anderson Cancer Center,"December 19, 2006",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00414076
Male Breast Cancer,NCT01703520,Merck Sharp & Dohme Corp.,"May 1, 2011",None,Observational,https://clinicaltrials.gov/show/NCT01703520
Uveal Melanoma,NCT00872391,Medical University of Vienna,March 2009,N/A,Interventional,https://clinicaltrials.gov/show/NCT00872391
Pheochromocytoma,NCT00874614,"Molecular Insight Pharmaceuticals, Inc.","June 4, 2009",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00874614
Kidney Cancer,NCT00873236,Mount Vernon Cancer Centre at Mount Vernon Hospital,April 2008,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00873236
Hodgkin Lymphoma,NCT00877747,Ospedale Santa Croce-Carle Cuneo,January 2006,None,Observational,https://clinicaltrials.gov/show/NCT00877747
Fallopian Tube Cancer,NCT00872989,Southwest Oncology Group,March 2010,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00872989
Fallopian Tube Cancer,NCT00870233,Memorial Sloan Kettering Cancer Center,"March 24, 2009",None,Observational,https://clinicaltrials.gov/show/NCT00870233
Primary Myelofibrosis,NCT04384692,Fred Hutchinson Cancer Research Center,"December 9, 2020",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04384692
Cholangiocarcinoma,NCT02073994,"Agios Pharmaceuticals, Inc.",March 2014,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT02073994
Kidney Cancer,NCT02073110,Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA),August 2013,None,Observational,https://clinicaltrials.gov/show/NCT02073110
Kidney Cancer,NCT00496756,University of Nebraska,March 2007,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00496756
Kidney Cancer,NCT00498966,AEterna Zentaris,July 2007,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00498966
Chondrosarcoma,NCT00496522,M.D. Anderson Cancer Center,April 2006,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00496522
Kidney Cancer,NCT00492440,Cytheris SA,May 2007,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00492440
Kidney Cancer,NCT00492258,Medical Research Council,June 2007,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00492258
Kidney Cancer,NCT00490698,M.D. Anderson Cancer Center,October 2006,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00490698
Adenoid Cystic Carcinoma,NCT03087019,Dana-Farber Cancer Institute,"April 25, 2017",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03087019
Kidney Cancer,NCT03414827,Zealand University Hospital,"February 1, 2019",None,Observational,https://clinicaltrials.gov/show/NCT03414827
Cholangiocarcinoma,NCT03414489,RedHill Biopharma Limited,None,None,Expanded Access,https://clinicaltrials.gov/show/NCT03414489
Uveal Melanoma,NCT03417739,Dana-Farber Cancer Institute,"March 26, 2018",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03417739
Kidney Cancer,NCT02828709,Dr. Prof. M.P. Laguna Pes,July 2016,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02828709
Adenoid Cystic Carcinoma,NCT01417143,Seoul National University Hospital,September 2011,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01417143
Pheochromocytoma,NCT01413503,"University of California, San Francisco",May 1991,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01413503
Richter's Transformation,NCT02138786,Karyopharm Therapeutics Inc,"November 14, 2014",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02138786
Mesothelioma,NCT02139904,Wales Cancer Trials Unit,"March 1, 2016",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02139904
Fallopian Tube Cancer,NCT00091377,"MEI Pharma, Inc.",August 2004,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00091377
Male Breast Cancer,NCT00096434,National Cancer Institute (NCI),September 2004,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00096434
Fallopian Tube Cancer,NCT00098878,NHS Greater Glasgow and Clyde,March 2004,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00098878
Male Breast Cancer,NCT00098397,National Cancer Institute (NCI),February 2005,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00098397
Kidney Cancer,NCT00093405,Memorial Sloan Kettering Cancer Center,August 2004,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00093405
Kidney Cancer,NCT00093522,St. Luke's Medical Center,August 2004,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00093522
Kidney Cancer,NCT00090870,Medical University of South Carolina,April 2002,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00090870
Leiomyosarcoma,NCT00093080,Merck Sharp & Dohme Corp.,October 2004,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00093080
Kidney Cancer,NCT00096629,Memorial Sloan Kettering Cancer Center,November 2003,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00096629
Male Breast Cancer,NCT00095888,National Cancer Institute (NCI),October 2004,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00095888
Kidney Cancer,NCT00096525,Memorial Sloan Kettering Cancer Center,July 2004,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00096525
Primary Myelofibrosis,NCT00095784,National Cancer Institute (NCI),"September 29, 2004",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00095784
Fallopian Tube Cancer,NCT00096239,Jonsson Comprehensive Cancer Center,December 2004,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00096239
Hodgkin Lymphoma,NCT03617666,"University College, London","September 27, 2019",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03617666
Hodgkin Lymphoma,NCT03618550,Memorial Sloan Kettering Cancer Center,"August 1, 2018",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03618550
Cholangiocarcinoma,NCT03613168,Changhoon Yoo,"June 1, 2019",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03613168
Adrenocortical Carcinoma,NCT03612232,Wuerzburg University Hospital,"June 4, 2019",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03612232
Mesothelioma,NCT03610360,Amphera BV,"June 21, 2018",Phase 2/Phase 3,Interventional,https://clinicaltrials.gov/show/NCT03610360
Hodgkin Lymphoma,NCT03613727,Virginia Commonwealth University,"October 1, 2018",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03613727
Thymoma,NCT03613272,Jiang Fan,"July 1, 2018",N/A,Interventional,https://clinicaltrials.gov/show/NCT03613272
Primary Myelofibrosis,NCT01423851,"NS Pharma, Inc.",June 2011,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01423851
Pheochromocytoma,NCT01425710,Medical University of Vienna,August 2011,None,Observational,https://clinicaltrials.gov/show/NCT01425710
Primary Myelofibrosis,NCT01423058,"Sierra Oncology, Inc.",August 2011,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01423058
Leiomyosarcoma,NCT01426633,Heidelberg University,November 2011,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT01426633
Uveal Melanoma,NCT04589832,"Arkadiusz Z. Dudek, MD",November 2020,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04589832
Uveal Melanoma,NCT04588662,Richard D. Carvajal,November 2020,None,Observational [Patient Registry],https://clinicaltrials.gov/show/NCT04588662
Cholangiocarcinoma,NCT00975039,Steba Biotech S.A.,September 2009,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00975039
Cholangiocarcinoma,NCT00973713,Austin Health,September 2009,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00973713
Male Breast Cancer,NCT01931709,University of Washington,November 2011,N/A,Interventional,https://clinicaltrials.gov/show/NCT01931709
Mesothelioma,NCT03063450,University of Southampton,"March 28, 2017",Phase 3,Interventional,https://clinicaltrials.gov/show/NCT03063450
Hodgkin Lymphoma,NCT02398240,Mitchell Cairo,May 2015,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02398240
Mesothelioma,NCT02395679,Erasmus Medical Center,January 2015,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT02395679
Thymoma,NCT00198133,Patrick Joseph Loehrer Sr.,January 2005,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00198133
Mesothelioma,NCT00190762,Eli Lilly and Company,October 2001,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00190762
Kidney Cancer,NCT00193154,"SCRI Development Innovations, LLC",February 2003,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00193154
Uveal Melanoma,NCT02517736,"University Hospital, Caen",February 2012,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02517736
Hodgkin Lymphoma,NCT03250962,Chinese PLA General Hospital,"September 11, 2017",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03250962
Adrenocortical Carcinoma,NCT03257891,Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia,"January 25, 2018",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03257891
Primary Myelofibrosis,NCT02091752,Novartis Pharmaceuticals,September 2014,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02091752
Adenoid Cystic Carcinoma,NCT02098538,Memorial Sloan Kettering Cancer Center,March 2014,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02098538
Hodgkin Lymphoma,NCT02098512,New York Medical College,March 2014,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02098512
Fibrolamellar Hepatocellular Carcinoma,NCT02702960,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,March 2016,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02702960
Mesothelioma,NCT02709512,Polaris Group,"August 1, 2017",Phase 2/Phase 3,Interventional,https://clinicaltrials.gov/show/NCT02709512
Cholangiocarcinoma,NCT01844245,Bing Hu,May 2013,N/A,Interventional,https://clinicaltrials.gov/show/NCT01844245
Kidney Cancer,NCT01971905,Nessn Azawi,February 2014,None,Observational,https://clinicaltrials.gov/show/NCT01971905
Chondrosarcoma,NCT02008019,Centre Leon Berard,"August 14, 2014",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02008019
Pheochromocytoma,NCT01022515,"University Hospital, Rouen",November 2008,None,Observational,https://clinicaltrials.gov/show/NCT01022515
Thymoma,NCT01025089,Memorial Sloan Kettering Cancer Center,December 2009,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01025089
Kidney Cancer,NCT01024205,Barts and the London School of Medicine and Dentistry,August 2007,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01024205
Hodgkin Lymphoma,NCT01022996,Novartis Pharmaceuticals,December 2009,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01022996
Mesothelioma,NCT04040231,Memorial Sloan Kettering Cancer Center,"July 24, 2019",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT04040231
Cutaneous T Cell Lymphoma,NCT04045470,Dana-Farber Cancer Institute,"November 27, 2019",N/A,Interventional,https://clinicaltrials.gov/show/NCT04045470
Chondrosarcoma,NCT04040205,Medical College of Wisconsin,"October 7, 2019",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04040205
Adenoid Cystic Carcinoma,NCT03999684,Dana-Farber Cancer Institute,"August 5, 2019",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03999684
Cholangiocarcinoma,NCT03999593,University of Liverpool,January 2009,None,Observational,https://clinicaltrials.gov/show/NCT03999593
Uveal Melanoma,NCT02376920,Castle Biosciences Incorporated,March 2010,None,Observational [Patient Registry],https://clinicaltrials.gov/show/NCT02376920
Richter's Transformation,NCT02378038,"Sierra Oncology, Inc.",August 2015,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02378038
Cholangiocarcinoma,NCT02374489,"National Health Research Institutes, Taiwan",March 2015,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02374489
Primary Myelofibrosis,NCT02370329,Mayo Clinic,August 2015,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02370329
Kidney Cancer,NCT04342286,Chinese University of Hong Kong,"May 1, 2020",None,Observational,https://clinicaltrials.gov/show/NCT04342286
Cholangiocarcinoma,NCT04340986,Assistance Publique - H√¥pitaux de Paris,April 2020,None,Observational,https://clinicaltrials.gov/show/NCT04340986
Adrenocortical Carcinoma,NCT02673333,Memorial Sloan Kettering Cancer Center,February 2016,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02673333
Cholangiocarcinoma,NCT00660140,Washington University School of Medicine,March 2002,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00660140
Mesothelioma,NCT00668499,University of Southern California,April 2008,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00668499
Uveal Melanoma,NCT00661622,Sidney Kimmel Cancer Center at Thomas Jefferson University,October 2004,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00661622
Hodgkin Lymphoma,NCT02432235,ADC Therapeutics S.A.,June 2015,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT02432235
Cholangiocarcinoma,NCT02436564,Cambridge University Hospitals NHS Foundation Trust,July 2015,None,Observational,https://clinicaltrials.gov/show/NCT02436564
Cholangiocarcinoma,NCT03943043,Istituto Clinico Humanitas,"July 21, 2017",Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03943043
Hodgkin Lymphoma,NCT03947255,Seagen Inc.,"October 28, 2019",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03947255
Pancreatic Neuroendocrine Tumor,NCT03947762,Ipsen,"July 3, 2019",None,Observational,https://clinicaltrials.gov/show/NCT03947762
Uterine Serous Carcinoma,NCT04590248,AstraZeneca,"December 11, 2020",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04590248
Mesothelioma,NCT02899299,Bristol-Myers Squibb,"October 25, 2016",Phase 3,Interventional,https://clinicaltrials.gov/show/NCT02899299
Mesothelioma,NCT02899195,"PrECOG, LLC.","June 13, 2017",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02899195
Adrenocortical Carcinoma,NCT02015026,National Cancer Institute (NCI),"December 13, 2013",None,Observational,https://clinicaltrials.gov/show/NCT02015026
Male Breast Cancer,NCT02013492,William Carson,"January 21, 2014",Early Phase 1,Interventional,https://clinicaltrials.gov/show/NCT02013492
Thymoma,NCT02014805,Chinese Academy of Medical Sciences,July 2013,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT02014805
Kidney Cancer,NCT02019693,National Cancer Institute (NCI),"January 24, 2014",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02019693
Hodgkin Lymphoma,NCT04298619,Federico II University,June 2001,None,Observational,https://clinicaltrials.gov/show/NCT04298619
Kaposi's Sarcoma,NCT02201420,Navidea Biopharmaceuticals,September 2014,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02201420
Male Breast Cancer,NCT00132002,National Cancer Institute (NCI),June 2005,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00132002
Mesothelioma,NCT00137826,Dana-Farber Cancer Institute,February 2004,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00137826
Fallopian Tube Cancer,NCT00138242,Floyd & Delores Jones Cancer Institute at Virginia Mason Medical Center,December 2004,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00138242
Male Breast Cancer,NCT00068588,National Cancer Institute (NCI),October 2003,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00068588
Fallopian Tube Cancer,NCT00066729,Memorial Sloan Kettering Cancer Center,May 2003,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00066729
Male Breast Cancer,NCT00063934,National Cancer Institute (NCI),May 2003,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00063934
Mesothelioma,NCT00061477,Eli Lilly and Company,December 2002,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00061477
Kidney Cancer,NCT00066599,National Cancer Institute (NCI),June 2003,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00066599
Penile Cancer,NCT00066391,European Organisation for Research and Treatment of Cancer - EORTC,June 2003,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00066391
Cholangiocarcinoma,NCT02482454,The First People's Hospital of Changzhou,July 2012,Phase 2/Phase 3,Interventional,https://clinicaltrials.gov/show/NCT02482454
Mesothelioma,NCT03867578,University of Chicago,"October 10, 2018",N/A,Interventional,https://clinicaltrials.gov/show/NCT03867578
Kidney Cancer,NCT01888042,"Gustave Roussy, Cancer Campus, Grand Paris",July 2011,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01888042
Adult T-cell Leukemia/Lymphoma,NCT04102150,"Daiichi Sankyo Co., Ltd.","November 21, 2019",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04102150
Cholangiocarcinoma,NCT04099888,PCI Biotech AS,"May 23, 2019",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04099888
Hodgkin Lymphoma,NCT04091490,"State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia","February 19, 2020",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04091490
Adenoid Cystic Carcinoma,NCT04209660,Memorial Sloan Kettering Cancer Center,"June 2, 2020",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04209660
Cholangiocarcinoma,NCT01900158,PCI Biotech AS,May 2013,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT01900158
Hodgkin Lymphoma,NCT01900509,St. Jude Children's Research Hospital,August 2013,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT01900509
Mesothelioma,NCT01907100,Boehringer Ingelheim,"September 19, 2013",Phase 2/Phase 3,Interventional,https://clinicaltrials.gov/show/NCT01907100
Heart Cancer,NCT02333279,University of Zurich,May 2008,None,Observational [Patient Registry],https://clinicaltrials.gov/show/NCT02333279
Gliosarcoma,NCT00613223,Annick Desjardins,February 2008,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00613223
Kidney Cancer,NCT00617799,University of Nebraska,October 2007,None,Observational,https://clinicaltrials.gov/show/NCT00617799
Gliosarcoma,NCT00612651,Duke University,October 2005,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00612651
Fallopian Tube Cancer,NCT00617773,Recepta Biopharma,May 2008,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00617773
Cholangiocarcinoma,NCT03792048,First Affiliated Hospital Xi'an Jiaotong University,"February 1, 2019",N/A,Interventional,https://clinicaltrials.gov/show/NCT03792048
Mesothelioma,NCT03907852,TCR2 Therapeutics,"April 15, 2019",Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03907852
Hodgkin Lymphoma,NCT01217229,"Daiichi Sankyo, Inc.","March 3, 2011",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01217229
Kidney Cancer,NCT01217931,M.D. Anderson Cancer Center,January 2011,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01217931
Leiomyosarcoma,NCT04535271,"Sarcoma Oncology Research Center, LLC","December 8, 2020",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04535271
Hypopharyngeal Cancer,NCT04539600,Sun Yat-sen University,"September 1, 2020",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04539600
Cholangiocarcinoma,NCT01267344,"National Health Research Institutes, Taiwan",December 2010,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01267344
Kidney Cancer,NCT01263769,M.D. Anderson Cancer Center,February 2011,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01263769
Hodgkin Lymphoma,NCT01263899,S*BIO,December 2010,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01263899
Kidney Cancer,NCT01264341,Hellenic Cooperative Oncology Group,December 2010,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01264341
Plasma Cell Leukemia,NCT03591744,City of Hope Medical Center,"October 25, 2018",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT03591744
Fallopian Tube Cancer,NCT03593681,Boston Scientific Corporation,"August 20, 2018",None,Observational,https://clinicaltrials.gov/show/NCT03593681
Hodgkin Lymphoma,NCT01569204,University of Cologne,October 2012,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01569204
Primary Myelofibrosis,NCT04283526,Novartis Pharmaceuticals,"November 30, 2020",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT04283526
Angiosarcoma,NCT02732678,Assistance Publique Hopitaux De Marseille,May 2016,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02732678
Gliosarcoma,NCT02311920,National Cancer Institute (NCI),"April 16, 2015",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT02311920
Mesothelioma,NCT02784171,Canadian Cancer Trials Group,"October 7, 2016",Phase 2/Phase 3,Interventional,https://clinicaltrials.gov/show/NCT02784171
Adenoid Cystic Carcinoma,NCT02780310,Memorial Sloan Kettering Cancer Center,"May 19, 2016",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02780310
Kidney Cancer,NCT01486550,Regional Hospital Holstebro,December 2011,Phase 4,Interventional,https://clinicaltrials.gov/show/NCT01486550
Mesothelioma,NCT03918252,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,"October 2, 2019",Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03918252
Hodgkin Lymphoma,NCT03436862,"SCRI Development Innovations, LLC","May 23, 2018",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03436862
Leiomyosarcoma,NCT03437070,University of Miami,June 2019,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT03437070
Mesothelioma,NCT03436732,National Cancer Institute (NCI),"February 28, 2018",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT03436732
Cholangiocarcinoma,NCT03438435,"D. Kim Turgeon, MD","April 22, 2019",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT03438435
Kidney Cancer,NCT03433534,"University Hospital, Tours","January 29, 2018",None,Observational,https://clinicaltrials.gov/show/NCT03433534
Kidney Cancer,NCT00031564,H. Lee Moffitt Cancer Center and Research Institute,May 2000,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00031564
Kidney Cancer,NCT00039429,Eastern Cooperative Oncology Group,May 2003,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00039429
Kidney Cancer,NCT00030888,"University of California, San Francisco",December 2002,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00030888
Kidney Cancer,NCT00039169,Theradex,December 2001,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00039169
Fallopian Tube Cancer,NCT00039585,National Cancer Institute (NCI),May 2002,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00039585
Fallopian Tube Cancer,NCT00030446,NCIC Clinical Trials Group,"January 10, 2002",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00030446
Fallopian Tube Cancer,NCT00031954,AGO Study Group,August 2001,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00031954
Male Breast Cancer,NCT00030615,National Cancer Institute (NCI),December 2001,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00030615
Richter's Transformation,NCT00472849,M.D. Anderson Cancer Center,May 2007,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00472849
Kidney Cancer,NCT03185039,Institut Paoli-Calmettes,"May 29, 2017",N/A,Interventional,https://clinicaltrials.gov/show/NCT03185039
Insulinoma,NCT03189953,Radboud University,April 2015,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03189953
Uveal Melanoma,NCT03712904,Sidney Kimmel Cancer Center at Thomas Jefferson University,"August 9, 2019",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03712904
Uveal Melanoma,NCT02874040,Institut Curie,"April 19, 2013",N/A,Interventional,https://clinicaltrials.gov/show/NCT02874040
Penile Cancer,NCT03391479,"University Health Network, Toronto","August 15, 2018",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03391479
Alveolar Soft Part Sarcoma,NCT03623581,"Genor Biopharma Co., Ltd.","September 6, 2018",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03623581
Kidney Cancer,NCT03623490,Centre Georges Francois Leclerc,"March 19, 2018",N/A,Interventional,https://clinicaltrials.gov/show/NCT03623490
Primary Myelofibrosis,NCT03627403,University of Utah,"March 14, 2019",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03627403
Cholangiocarcinoma,NCT04037007,"Coordinaci√≥n de Investigaci√≥n en Salud, Mexico","July 3, 2019",N/A,Interventional,https://clinicaltrials.gov/show/NCT04037007
Mesothelioma,NCT02860286,"Epizyme, Inc.",July 2016,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02860286
Kaposi's Sarcoma,NCT01067690,"Barbara Ensoli, MD, PhD",June 2008,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01067690
Kidney Cancer,NCT01751529,UNC Lineberger Comprehensive Cancer Center,May 2013,Early Phase 1,Interventional,https://clinicaltrials.gov/show/NCT01751529
Cholangiocarcinoma,NCT01755013,Weill Medical College of Cornell University,February 2012,Phase 2/Phase 3,Interventional,https://clinicaltrials.gov/show/NCT01755013
Hodgkin Lymphoma,NCT02280993,Marjolein Spiering,May 2014,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT02280993
Fallopian Tube Cancer,NCT00238342,Gynecologic Oncology Group,October 2005,N/A,Interventional,https://clinicaltrials.gov/show/NCT00238342
Cholangiocarcinoma,NCT00230347,Stanford University,October 2003,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00230347
Adrenocortical Carcinoma,NCT03127774,Columbia University,"September 22, 2017",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03127774
Hodgkin Lymphoma,NCT03120676,Memorial Sloan Kettering Cancer Center,"April 14, 2017",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03120676
Adenoid Cystic Carcinoma,NCT01586767,Massachusetts General Hospital,July 2011,N/A,Interventional,https://clinicaltrials.gov/show/NCT01586767
Hodgkin Lymphoma,NCT04396119,The Christie NHS Foundation Trust,"February 11, 2020",None,Observational,https://clinicaltrials.gov/show/NCT04396119
Kidney Cancer,NCT04393350,Emory University,"June 22, 2020",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04393350
Gliosarcoma,NCT04396860,National Cancer Institute (NCI),"August 6, 2020",Phase 2/Phase 3,Interventional,https://clinicaltrials.gov/show/NCT04396860
Hodgkin Lymphoma,NCT03730363,Reinhold Munker,"December 19, 2018",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT03730363
Cholangiocarcinoma,NCT01963325,Yuhong Li,August 2013,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01963325
Pheochromocytoma,NCT01967576,National Cancer Institute (NCI),"October 19, 2013",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01967576
Mucosal Melanoma,NCT01961115,Fred Hutchinson Cancer Research Center,"September 13, 2013",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01961115
Primary Myelofibrosis,NCT01969838,"Sierra Oncology, Inc.","December 6, 2013",Phase 3,Interventional,https://clinicaltrials.gov/show/NCT01969838
Ependymoma,NCT01117155,National Cancer Institute (NCI),"April 23, 2010",None,Observational,https://clinicaltrials.gov/show/NCT01117155
Mesothelioma,NCT01119664,Abramson Cancer Center of the University of Pennsylvania,"April 27, 2010",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT01119664
Hodgkin Lymphoma,NCT02763254,Cell Medica Ltd,November 2016,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02763254
Uveal Melanoma,NCT02768766,Richard D. Carvajal,"February 28, 2017",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT02768766
Primary Myelofibrosis,NCT02760238,"University Health Network, Toronto",April 2016,None,Observational [Patient Registry],https://clinicaltrials.gov/show/NCT02760238
Cholangiocarcinoma,NCT00320918,University of New Mexico,November 2005,None,Observational,https://clinicaltrials.gov/show/NCT00320918
T-cell Lymphoma,NCT00322985,AHS Cancer Control Alberta,June 2006,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00322985
Kidney Cancer,NCT00323739,"SCRI Development Innovations, LLC",May 2006,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00323739
Adrenocortical Carcinoma,NCT00324012,"Rigshospitalet, Denmark",April 2006,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00324012
Kidney Cancer,NCT00323791,University of Medicine and Dentistry of New Jersey,April 2006,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00323791
Primary Myelofibrosis,NCT01731951,Geron Corporation,"October 31, 2012",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01731951
Cholangiocarcinoma,NCT01739465,Guangzhou Medical University,November 2012,Phase 2/Phase 3,Interventional,https://clinicaltrials.gov/show/NCT01739465
Uveal Melanoma,NCT04184518,Grupo Espa√±ol Multidisciplinar de Melanoma,May 2020,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04184518
Adrenocortical Carcinoma,NCT04187404,Enterome,"July 23, 2020",Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04187404
Insulinoma,NCT04185350,"Nanjing First Hospital, Nanjing Medical University","May 5, 2019",Early Phase 1,Interventional,https://clinicaltrials.gov/show/NCT04185350
Mucosal Melanoma,NCT04180995,Beijing Cancer Hospital,"August 6, 2019",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04180995
Hodgkin Lymphoma,NCT01356680,University of Cologne,"January 13, 2012",Phase 3,Interventional,https://clinicaltrials.gov/show/NCT01356680
Mesothelioma,NCT01356251,Memorial Sloan Kettering Cancer Center,May 2011,N/A,Interventional,https://clinicaltrials.gov/show/NCT01356251
Cholangiocarcinoma,NCT01145248,University of Ulm,January 2006,N/A,Interventional,https://clinicaltrials.gov/show/NCT01145248
Fallopian Tube Cancer,NCT01591772,Memorial Sloan Kettering Cancer Center,April 2012,None,Observational,https://clinicaltrials.gov/show/NCT01591772
Mesothelioma,NCT01590472,Wake Forest University,June 2011,None,Observational,https://clinicaltrials.gov/show/NCT01590472
Cholangiocarcinoma,NCT02609958,Aslan Pharmaceuticals,"November 16, 2015",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02609958
Uveal Melanoma,NCT02601378,Novartis Pharmaceuticals,"February 1, 2016",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT02601378
Cholangiocarcinoma,NCT02607826,University Hospital Tuebingen,November 2016,N/A,Interventional,https://clinicaltrials.gov/show/NCT02607826
Gliosarcoma,NCT04216329,National Cancer Institute (NCI),"July 7, 2020",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT04216329
Adenoid Cystic Carcinoma,NCT04214366,Heidelberg University,"December 15, 2019",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04214366
Mesothelioma,NCT04214015,ProgenaBiome,"March 2, 2020",None,Observational,https://clinicaltrials.gov/show/NCT04214015
Fallopian Tube Cancer,NCT00275028,National Cancer Institute (NCI),October 2005,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00275028
Kidney Cancer,NCT00278174,Case Comprehensive Cancer Center,February 2005,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00278174
Kidney Cancer,NCT00278369,Northwestern University,April 2005,Early Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00278369
Kidney Cancer,NCT00276614,Jonsson Comprehensive Cancer Center,April 2006,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00276614
Kidney Cancer,NCT00276835,Northwestern University,November 2005,Early Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00276835
Hodgkin Lymphoma,NCT03495713,Abramson Cancer Center of the University of Pennsylvania,"March 2, 2018",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03495713
Cholangiocarcinoma,NCT03499782,"Xinhua Hospital, Shanghai Jiao Tong University School of Medicine","May 25, 2018",None,Observational,https://clinicaltrials.gov/show/NCT03499782
Kidney Cancer,NCT00943839,Centre Antoine Lacassagne,February 2009,N/A,Interventional,https://clinicaltrials.gov/show/NCT00943839
Kidney Cancer,NCT00550654,National Institutes of Health Clinical Center (CC),October 2007,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00550654
Fallopian Tube Cancer,NCT00550784,City of Hope Medical Center,January 2001,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00550784
Mesothelioma,NCT00551252,Gruppo Italiano MEsotelioma,January 2008,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00551252
Adrenocortical Carcinoma,NCT01833832,National Cancer Institute (NCI),"April 12, 2013",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01833832
Adrenocortical Carcinoma,NCT01832974,INSYS Therapeutics Inc,December 2012,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT01832974
Cholangiocarcinoma,NCT00955721,University of Miami,August 2009,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00955721
T-cell Lymphoma,NCT00959686,French Innovative Leukemia Organisation,September 2009,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00959686
Penile Cancer,NCT00955929,Memorial Sloan Kettering Cancer Center,August 2009,N/A,Interventional,https://clinicaltrials.gov/show/NCT00955929
Fallopian Tube Cancer,NCT00354601,Wake Forest University Health Sciences,January 2006,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00354601
Cholangiocarcinoma,NCT00350961,"Rigshospitalet, Denmark",June 2004,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00350961
Cholangiocarcinoma,NCT00350753,"Rigshospitalet, Denmark",June 2006,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00350753
Fallopian Tube Cancer,NCT00357448,University of Washington,April 2005,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00357448
Fallopian Tube Cancer,NCT00373217,"Craig L Slingluff, Jr",February 2008,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00373217
Uveal Melanoma,NCT02626962,Grupo Espa√±ol Multidisciplinar de Melanoma,April 2016,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02626962
Thymic Carcinoma,NCT02623127,Seoul National University Hospital,October 2015,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02623127
Mesothelioma,NCT02628535,MacroGenics,September 2015,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT02628535
Cholangiocarcinoma,NCT02626312,M.D. Anderson Cancer Center,"February 15, 2016",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT02626312
Pancreatic Neuroendocrine Tumor,NCT02624154,"First Affiliated Hospital, Sun Yat-Sen University",December 2015,None,Observational,https://clinicaltrials.gov/show/NCT02624154
Hodgkin Lymphoma,NCT02624258,University of Pennsylvania,November 2015,Early Phase 1,Interventional,https://clinicaltrials.gov/show/NCT02624258
Mucosal Melanoma,NCT03138642,Sun Yat-sen University,"July 1, 2010",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03138642
Hodgkin Lymphoma,NCT03131531,A.O. Ospedale Papa Giovanni XXIII,"March 23, 2017",None,Observational [Patient Registry],https://clinicaltrials.gov/show/NCT03131531
Primary Myelofibrosis,NCT02251821,Fred Hutchinson Cancer Research Center,"October 20, 2014",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02251821
NUT Midline Carcinoma,NCT02259114,Oncoethix GmbH,"October 23, 2014",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT02259114
Primary Myelofibrosis,NCT02426086,Geron Corporation,"June 2, 2015",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02426086
Hodgkin Lymphoma,NCT02429375,Memorial Sloan Kettering Cancer Center,April 2015,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02429375
Cholangiocarcinoma,NCT02428855,Massachusetts General Hospital,April 2015,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02428855
T-cell Lymphoma,NCT02424045,Samsung Medical Center,May 2015,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02424045
Hodgkin Lymphoma,NCT01008735,Gruppo Italiano Studio Linfomi,July 2009,None,Observational,https://clinicaltrials.gov/show/NCT01008735
Cholangiocarcinoma,NCT01007552,Roswell Park Cancer Institute,December 2009,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01007552
Kidney Cancer,NCT01004783,Children's Oncology Group,October 2009,None,Observational,https://clinicaltrials.gov/show/NCT01004783
Hodgkin Lymphoma,NCT02321592,University of Cologne,May 2015,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02321592
Hypopharyngeal Cancer,NCT03558035,Chinese Academy of Medical Sciences,September 2014,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03558035
Kidney Cancer,NCT03556943,"Ceevra, Inc.","May 15, 2018",N/A,Interventional,https://clinicaltrials.gov/show/NCT03556943
Adenoid Cystic Carcinoma,NCT01192087,Heidelberg University,June 2012,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01192087
Hodgkin Lymphoma,NCT03681561,Veronika Bachanova,"September 13, 2018",Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03681561
Penile Cancer,NCT03686332,The Netherlands Cancer Institute,"September 25, 2018",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03686332
Mesothelioma,NCT03683680,Dana-Farber Cancer Institute,"October 31, 2018",N/A,Interventional,https://clinicaltrials.gov/show/NCT03683680
Waldenstr√∂m's Macroglobulinemia,NCT02165397,Pharmacyclics LLC.,"July 7, 2014",Phase 3,Interventional,https://clinicaltrials.gov/show/NCT02165397
Cholangiocarcinoma,NCT02162914,Erasme University Hospital,"March 14, 2014",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02162914
Uveal Melanoma,NCT02913417,"David Minor, MD",October 2016,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02913417
Primary Myelofibrosis,NCT02917096,City of Hope Medical Center,"October 5, 2016",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT02917096
Cholangiocarcinoma,NCT03102268,The Second Hospital of Nanjing Medical University,"May 1, 2017",None,Observational [Patient Registry],https://clinicaltrials.gov/show/NCT03102268
Adrenocortical Carcinoma,NCT00786110,"University of Turin, Italy",April 2008,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00786110
Mesothelioma,NCT00787410,AstraZeneca,September 2003,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00787410
Thymoma,NCT00589290,National Cancer Institute (NCI),December 2007,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00589290
Kidney Cancer,NCT00588913,Tokyo Women's Medical University,January 2006,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00588913
Kidney Cancer,NCT00589550,Thomas Olencki,February 2008,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00589550
Kidney Cancer,NCT00582790,"University of Wisconsin, Madison",August 2003,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00582790
Adenoid Cystic Carcinoma,NCT00581360,University of Pittsburgh,November 2007,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00581360
Pheochromocytoma,NCT00911729,"Molecular Insight Pharmaceuticals, Inc.",April 2009,None,Observational,https://clinicaltrials.gov/show/NCT00911729
Hodgkin Lymphoma,NCT01453504,University of Cologne,August 2012,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01453504
Cholangiocarcinoma,NCT04480190,Jordan Kharofa,"September 1, 2020",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT04480190
Mesothelioma,NCT04481672,Dana-Farber Cancer Institute,December 2020,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT04481672
Hodgkin Lymphoma,NCT00982449,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,December 2010,N/A,Interventional,https://clinicaltrials.gov/show/NCT00982449
Hodgkin Lymphoma,NCT02247869,Fondazione Italiana Linfomi ONLUS,February 2012,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02247869
Leiomyosarcoma,NCT02249702,Mario Negri Institute for Pharmacological Research,April 2010,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02249702
Kidney Cancer,NCT00717587,Abramson Cancer Center of the University of Pennsylvania,June 2008,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00717587
Mesothelioma,NCT00715611,Memorial Sloan Kettering Cancer Center,"October 11, 2008",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00715611
Cholangiocarcinoma,NCT00713687,Technische Universit√§t M√ºnchen,August 2008,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00713687
Primary Myelofibrosis,NCT01981850,Hoffmann-La Roche,"October 1, 2013",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01981850
Uveal Melanoma,NCT01983748,University Hospital Erlangen,June 2014,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT01983748
Male Breast Cancer,NCT01982591,Fox Chase Cancer Center,"January 3, 2011",None,Observational,https://clinicaltrials.gov/show/NCT01982591
Uveal Melanoma,NCT02771340,"Iconic Therapeutics, Inc.",May 2016,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT02771340
Adenoid Cystic Carcinoma,NCT02775370,Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University,May 2016,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02775370
Cholangiocarcinoma,NCT02773485,Tata Memorial Hospital,May 2015,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT02773485
Male Breast Cancer,NCT02046421,University of Chicago,November 2013,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT02046421
Mesothelioma,NCT02040272,Royal Brompton & Harefield NHS Foundation Trust,May 2015,N/A,Interventional,https://clinicaltrials.gov/show/NCT02040272
Kidney Cancer,NCT00405366,UNC Lineberger Comprehensive Cancer Center,November 2006,Early Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00405366
Kidney Cancer,NCT00401128,The Cleveland Clinic,May 2004,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00401128
Mesothelioma,NCT00407459,"Armando Santoro, MD",September 2007,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00407459
Mesothelioma,NCT00402766,M.D. Anderson Cancer Center,August 2006,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00402766
Kidney Cancer,NCT00403169,The Cleveland Clinic,August 2004,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00403169
Adult T-Cell Leukemia/Lymphoma,NCT03113500,City of Hope Medical Center,"May 25, 2017",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03113500
Gliosarcoma,NCT03115333,ECOG-ACRIN Cancer Research Group,"April 14, 2017",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03115333
Hodgkin Lymphoma,NCT03033914,Memorial Sloan Kettering Cancer Center,"January 25, 2017",Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03033914
Fallopian Tube Cancer,NCT00574951,Gynecologic Oncology Group,December 2007,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00574951
Pancreatic Neuroendocrine Tumor,NCT00576680,Dana-Farber Cancer Institute,May 2008,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00576680
Parathyroid Carcinoma,NCT03046524,M.D. Anderson Cancer Center,"October 6, 2015",None,Observational,https://clinicaltrials.gov/show/NCT03046524
Cholangiocarcinoma,NCT03042182,Immunitor LLC,"February 20, 2017",Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03042182
Pleuropulmonary Blastoma,NCT03044834,Rennes University Hospital,"January 9, 2017",None,Observational,https://clinicaltrials.gov/show/NCT03044834
Hodgkin Lymphoma,NCT03343665,St. Petersburg State Pavlov Medical University,"August 1, 2017",Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03343665
Pheochromocytoma,NCT03344016,Felix Beuschlein,"November 1, 2017",N/A,Interventional,https://clinicaltrials.gov/show/NCT03344016
Primary Myelofibrosis,NCT01178281,Celgene,"September 8, 2010",Phase 3,Interventional,https://clinicaltrials.gov/show/NCT01178281
Gliosarcoma,NCT03641326,National Cancer Institute (NCI),"February 21, 2019",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03641326
Mesothelioma,NCT03644550,National Cancer Institute (NCI),"December 4, 2018",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03644550
Hodgkin Lymphoma,NCT03646123,Seagen Inc.,"January 28, 2019",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03646123
Kidney Cancer,NCT01314391,Children's Oncology Group,August 2011,None,Observational,https://clinicaltrials.gov/show/NCT01314391
Hypopharyngeal Cancer,NCT01312350,Samsung Medical Center,November 2010,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01312350
Cutaneous T Cell Lymphoma,NCT02539472,Assistance Publique - H√¥pitaux de Paris,November 2015,N/A,Interventional,https://clinicaltrials.gov/show/NCT02539472
Kidney Cancer,NCT02298608,Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA),January 2014,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02298608
Hodgkin Lymphoma,NCT02298283,The Lymphoma Academic Research Organisation,April 2015,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02298283
Hodgkin Lymphoma,NCT02292979,The Lymphoma Academic Research Organisation,March 2015,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02292979
Mesothelioma,NCT00040625,Eli Lilly and Company,None,None,Expanded Access,https://clinicaltrials.gov/show/NCT00040625
Male Breast Cancer,NCT00045188,National Cancer Institute (NCI),August 2002,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00045188
Kidney Cancer,NCT00045279,Memorial Sloan Kettering Cancer Center,April 2002,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00045279
Fallopian Tube Cancer,NCT00045461,Ludwig-Maximilians - University of Munich,June 2000,Phase 2/Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00045461
Kidney Cancer,NCT00045487,The University of Texas Health Science Center at San Antonio,June 2002,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00045487
Kidney Cancer,NCT00042965,Alliance for Clinical Trials in Oncology,October 2002,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00042965
Kidney Cancer,NCT00045370,Memorial Sloan Kettering Cancer Center,April 2002,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00045370
Kidney Cancer,NCT00047138,University of Leicester,January 2001,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00047138
Fallopian Tube Cancer,NCT00041080,National Cancer Institute (NCI),February 2003,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00041080
Fallopian Tube Cancer,NCT00045175,"University Health Network, Toronto",June 2002,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00045175
Mesothelioma,NCT01204203,University of Alabama at Birmingham,June 2009,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01204203
Cholangiocarcinoma,NCT01206049,Vejle Hospital,September 2010,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01206049
Fallopian Tube Cancer,NCT01204749,Amgen,November 2010,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT01204749
Male Breast Cancer,NCT00821964,University of Washington,December 2008,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00821964
Mesothelioma,NCT03319537,Memorial Sloan Kettering Cancer Center,"October 5, 2017",Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03319537
Mucosal Melanoma,NCT03319693,CHU de Reims,"August 28, 2017",None,Observational,https://clinicaltrials.gov/show/NCT03319693
Mesothelioma,NCT01719068,British Columbia Cancer Agency,October 2012,None,Observational,https://clinicaltrials.gov/show/NCT01719068
Hodgkin Lymphoma,NCT01712490,"Millennium Pharmaceuticals, Inc.","November 9, 2012",Phase 3,Interventional,https://clinicaltrials.gov/show/NCT01712490
Leiomyosarcoma,NCT03509207,Medical University of Graz,"December 14, 2017",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03509207
Hodgkin Lymphoma,NCT03505996,CStone Pharmaceuticals,"June 1, 2018",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03505996
Cholangiocarcinoma,NCT02659852,Yonsei University,January 2016,N/A,Interventional,https://clinicaltrials.gov/show/NCT02659852
Kidney Cancer,NCT00831480,Linda C. Higgins,April 2011,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00831480
Fallopian Tube Cancer,NCT00838656,Warwick Medical School,October 2007,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00838656
Male Breast Cancer,NCT00343863,University of Washington,January 2006,N/A,Interventional,https://clinicaltrials.gov/show/NCT00343863
Alveolar Soft Part Sarcoma,NCT00340353,National Cancer Institute (NCI),"April 7, 2005",None,Observational,https://clinicaltrials.gov/show/NCT00340353
Male Breast Cancer,NCT00348699,National Cancer Institute (NCI),July 2006,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00348699
Kidney Cancer,NCT00340457,National Cancer Institute (NCI),"November 15, 2001",None,Observational,https://clinicaltrials.gov/show/NCT00340457
Uveal Melanoma,NCT02273219,Richard D. Carvajal,November 2014,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT02273219
Hodgkin Lymphoma,NCT02275598,University of Modena and Reggio Emilia,April 2013,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02275598
Chondrosarcoma,NCT04278781,Memorial Sloan Kettering Cancer Center,"March 4, 2020",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04278781
Pheochromocytoma,NCT03839498,Columbia University,"January 22, 2019",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03839498
Mesothelioma,NCT03830229,National Cancer Institute (NCI),"March 13, 2019",None,Observational,https://clinicaltrials.gov/show/NCT03830229
Kidney Cancer,NCT03354390,"National Heart, Lung, and Blood Institute (NHLBI)","July 20, 2018",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT03354390
Adenoid Cystic Carcinoma,NCT01558661,Memorial Sloan Kettering Cancer Center,March 2012,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01558661
Kidney Cancer,NCT01550393,Children's Oncology Group,March 2012,None,Observational,https://clinicaltrials.gov/show/NCT01550393
T-cell Lymphoma,NCT01553786,The Lymphoma Academic Research Organisation,November 2011,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01553786
Fallopian Tube Cancer,NCT01570582,Korean Gynecologic Oncology Group,March 2010,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01570582
Kidney Cancer,NCT01576198,Children's Oncology Group,April 2012,None,Observational,https://clinicaltrials.gov/show/NCT01576198
Kidney Cancer,NCT01576211,Children's Oncology Group,April 2012,None,Observational,https://clinicaltrials.gov/show/NCT01576211
Cholangiocarcinoma,NCT02924376,Incyte Corporation,"January 16, 2017",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02924376
Hodgkin Lymphoma,NCT02572167,Seagen Inc.,"October 31, 2015",Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02572167
Uveal Melanoma,NCT02570308,Immunocore Ltd,February 2016,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02570308
Alveolar Soft Part Sarcoma,NCT02636725,"Jonathan Trent, MD, PhD","April 19, 2016",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02636725
Thymoma,NCT02633553,Fudan University,"January 10, 2018",Phase 3,Interventional,https://clinicaltrials.gov/show/NCT02633553
Mesothelioma,NCT02838745,Baylor College of Medicine,September 2016,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT02838745
Cholangiocarcinoma,NCT00869635,Asan Medical Center,February 2009,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00869635
Kidney Cancer,NCT00866320,Case Comprehensive Cancer Center,February 2006,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00866320
Thymic Carcinoma,NCT04469725,"Jiangsu Alphamab Biopharmaceuticals Co., Ltd","August 31, 2020",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04469725
Uveal Melanoma,NCT04463368,"Sahlgrenska University Hospital, Sweden","January 1, 2021",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT04463368
Mucosal Melanoma,NCT04462965,Beijing Cancer Hospital,"May 30, 2020",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04462965
Mesothelioma,NCT00685204,Taxolog Inc.,March 2008,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00685204
Kaposi's Sarcoma,NCT00686842,AIDS Malignancy Consortium,September 2008,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00686842
Kidney Cancer,NCT04623502,University of Texas Southwestern Medical Center,"September 30, 2019",N/A,Interventional,https://clinicaltrials.gov/show/NCT04623502
Leiomyosarcoma,NCT04624178,Memorial Sloan Kettering Cancer Center,"November 5, 2020",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04624178
Mucosal Melanoma,NCT04622566,Beijing Cancer Hospital,"December 30, 2020",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04622566
Hodgkin Lymphoma,NCT04621604,Rennes University Hospital,"January 15, 2021",N/A,Interventional,https://clinicaltrials.gov/show/NCT04621604
Sacrococcygeal Teratoma,NCT04623658,Assistance Publique - H√¥pitaux de Paris,November 2020,None,Observational,https://clinicaltrials.gov/show/NCT04623658
Cutaneous T Cell Lymphoma,NCT03932279,Northwestern University,"January 30, 2019",None,Observational,https://clinicaltrials.gov/show/NCT03932279
Kidney Cancer,NCT01120249,Southwest Oncology Group,April 2011,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT01120249
Mesothelioma,NCT02648763,Mayo Clinic,"March 14, 2016",None,Observational,https://clinicaltrials.gov/show/NCT02648763
Cholangiocarcinoma,NCT02649712,Xuzhou Central Hospital,"January 20, 2016",N/A,Interventional,https://clinicaltrials.gov/show/NCT02649712
Cholangiocarcinoma,NCT03769753,Memorial Sloan Kettering Cancer Center,"December 5, 2018",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03769753
Leiomyosarcoma,NCT03761095,PTC Therapeutics,"March 13, 2019",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT03761095
Primary Myelofibrosis,NCT03755518,Celgene,"March 27, 2019",Phase 3,Interventional,https://clinicaltrials.gov/show/NCT03755518
Hodgkin Lymphoma,NCT03755804,St. Jude Children's Research Hospital,"December 12, 2018",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03755804
Kidney Cancer,NCT00489710,University of Nebraska,December 2006,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00489710
Fallopian Tube Cancer,NCT00483782,Medical Research Council,April 2006,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00483782
Male Breast Cancer,NCT03240510,Salah Aza√Øz Cancer Institute,"January 1, 2014",None,Observational,https://clinicaltrials.gov/show/NCT03240510
Mucosal Melanoma,NCT03241186,"Robert R. McWilliams, MD","September 12, 2017",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03241186
Hodgkin Lymphoma,NCT03242902,The Netherlands Cancer Institute,"September 20, 2017",Phase 3,Interventional,https://clinicaltrials.gov/show/NCT03242902
Cutaneous T Cell Lymphoma,NCT03235869,University of Michigan Rogel Cancer Center,"March 1, 2018",Early Phase 1,Interventional,https://clinicaltrials.gov/show/NCT03235869
Hodgkin Lymphoma,NCT01333046,Baylor College of Medicine,January 2012,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT01333046
Hodgkin Lymphoma,NCT01333605,Fudan University,April 2011,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01333605
Uveal Melanoma,NCT01338389,Centre Hospitalier Universitaire de Nice,"June 25, 2012",N/A,Interventional,https://clinicaltrials.gov/show/NCT01338389
Chondrosarcoma,NCT01330966,George Clinical Pty Ltd,April 2011,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01330966
Adenoid Cystic Carcinoma,NCT00886132,"University Health Network, Toronto",January 2007,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00886132
Uveal Melanoma,NCT01924923,Greater Houston Retina Research,June 2013,None,Observational,https://clinicaltrials.gov/show/NCT01924923
Cholangiocarcinoma,NCT01920503,International Group of Endovascular Oncology,July 2013,None,Observational [Patient Registry],https://clinicaltrials.gov/show/NCT01920503
Fallopian Tube Cancer,NCT00305838,Mount Vernon Cancer Centre at Mount Vernon Hospital,March 2004,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00305838
Kidney Cancer,NCT00303732,"Daniel George, MD",December 2004,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00303732
Fallopian Tube Cancer,NCT00303888,Yale University,May 2006,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00303888
Kidney Cancer,NCT00301847,National Cancer Institute (NCI),November 2005,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00301847
Cholangiocarcinoma,NCT00301379,Washington University School of Medicine,"August 12, 2005",None,Observational,https://clinicaltrials.gov/show/NCT00301379
Kidney Cancer,NCT00301990,Jonsson Comprehensive Cancer Center,September 2005,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00301990
Kidney Cancer,NCT00303719,"Masonic Cancer Center, University of Minnesota","March 26, 2002",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00303719
Hodgkin Lymphoma,NCT00301314,Royal Marsden NHS Foundation Trust,None,None,Observational,https://clinicaltrials.gov/show/NCT00301314
Kidney Cancer,NCT00505310,M.D. Anderson Cancer Center,"August 21, 2002",N/A,Interventional,https://clinicaltrials.gov/show/NCT00505310
Wilms' Tumor,NCT00503893,M.D. Anderson Cancer Center,"December 1, 1980",None,Observational,https://clinicaltrials.gov/show/NCT00503893
Fallopian Tube Cancer,NCT00504257,H. Lee Moffitt Cancer Center and Research Institute,March 2007,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00504257
Kidney Cancer,NCT02186925,Meir Medical Center,August 2014,None,Observational,https://clinicaltrials.gov/show/NCT02186925
Cholangiocarcinoma,NCT02181634,"PrECOG, LLC.","December 9, 2014",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02181634
Alveolar Soft Part Sarcoma,NCT02180867,National Cancer Institute (NCI),"July 11, 2014",Phase 2/Phase 3,Interventional,https://clinicaltrials.gov/show/NCT02180867
Primary Myelofibrosis,NCT04173494,"Sierra Oncology, Inc.","November 20, 2019",Phase 3,Interventional,https://clinicaltrials.gov/show/NCT04173494
Juvenile Myelomonocytic Leukemia,NCT03326921,Fred Hutchinson Cancer Research Center,"February 23, 2018",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT03326921
Fallopian Tube Cancer,NCT01402271,European Organisation for Research and Treatment of Cancer - EORTC,July 2012,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01402271
Pheochromocytoma,NCT02961491,"Molecular Insight Pharmaceuticals, Inc.",None,None,Expanded Access,https://clinicaltrials.gov/show/NCT02961491
Kidney Cancer,NCT02964078,H. Lee Moffitt Cancer Center and Research Institute,"April 25, 2017",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02964078
Primary Myelofibrosis,NCT02966353,Novartis Pharmaceuticals,"March 31, 2017",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02966353
Cholangiocarcinoma,NCT02170090,Universit√§tsklinikum Hamburg-Eppendorf,April 2014,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT02170090
Fallopian Tube Cancer,NCT00693342,Gynecologic Oncology Group,None,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00693342
Cholangiocarcinoma,NCT03140007,"Asian Institute of Gastroenterology, India","June 15, 2017",N/A,Interventional,https://clinicaltrials.gov/show/NCT03140007
Kidney Cancer,NCT01230697,"University of Turin, Italy",June 2010,None,Observational,https://clinicaltrials.gov/show/NCT01230697
Primary Myelofibrosis,NCT01236638,"Sierra Oncology, Inc.",November 2010,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01236638
Pheochromocytoma,NCT04605848,University of Avignon,"July 3, 2020",N/A,Interventional,https://clinicaltrials.gov/show/NCT04605848
Angiosarcoma,NCT04607200,Agenus Inc.,October 2020,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04607200
Hodgkin Lymphoma,NCT04514081,Chinese PLA General Hospital,"August 1, 2020",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04514081
Kidney Cancer,NCT04513522,Bristol-Myers Squibb,"August 31, 2020",Phase 4,Interventional,https://clinicaltrials.gov/show/NCT04513522
Hodgkin Lymphoma,NCT04510610,Chinese PLA General Hospital,"September 1, 2019",Phase 2/Phase 3,Interventional,https://clinicaltrials.gov/show/NCT04510610
Angiosarcoma,NCT04518124,The Netherlands Cancer Institute,"December 27, 2019",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04518124
Mesothelioma,NCT04515836,University of Chicago,"December 15, 2020",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04515836
Fallopian Tube Cancer,NCT01079832,Case Comprehensive Cancer Center,May 2009,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01079832
Fallopian Tube Cancer,NCT01074398,Gynecologic Oncology Group,February 2010,None,Observational,https://clinicaltrials.gov/show/NCT01074398
Fallopian Tube Cancer,NCT00382811,"MEI Pharma, Inc.",October 2006,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00382811
Thymoma,NCT00387868,Valley Health System,October 2006,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00387868
Kidney Cancer,NCT00243009,OHSU Knight Cancer Institute,June 2005,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00243009
Male Breast Cancer,NCT00244881,National Cancer Institute (NCI),September 2005,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00244881
Dermatofibrosarcoma Protuberans,NCT00243191,Sarcoma Alliance for Research through Collaboration,May 2006,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00243191
Primary Myelofibrosis,NCT02386800,Novartis Pharmaceuticals,"March 5, 2015",Phase 4,Interventional,https://clinicaltrials.gov/show/NCT02386800
Adrenocortical Carcinoma,NCT00469469,Dartmouth-Hitchcock Medical Center,May 2007,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00469469
Kidney Cancer,NCT00467077,California Cancer Consortium,September 2004,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00467077
Mesothelioma,NCT00469196,AHS Cancer Control Alberta,October 2006,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00469196
Kidney Cancer,NCT00462982,Memorial Sloan Kettering Cancer Center,March 2007,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00462982
Mesothelioma,NCT04153565,Merck Sharp & Dohme Corp.,"December 9, 2019",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT04153565
Primary Myelofibrosis,NCT01787552,Novartis Pharmaceuticals,"May 8, 2013",Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01787552
Waldenstr√∂m's Macroglobulinemia,NCT01788020,University of Ulm,November 2013,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT01788020
Angiosarcoma,NCT01786889,Centre Oscar Lambret,June 2013,N/A,Interventional,https://clinicaltrials.gov/show/NCT01786889
Primary Myelofibrosis,NCT03952039,Celgene,"September 9, 2019",Phase 3,Interventional,https://clinicaltrials.gov/show/NCT03952039
T-cell Lymphoma,NCT03952078,"Corvus Pharmaceuticals, Inc.","May 3, 2019",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT03952078
Cholangiocarcinoma,NCT01855724,Hellenic Cooperative Oncology Group,"June 28, 2013",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01855724
T-cell Lymphoma,NCT01854112,Far Eastern Memorial Hospital,November 2012,None,Observational,https://clinicaltrials.gov/show/NCT01854112
Cholangiocarcinoma,NCT01859169,li xiong,June 2013,None,Observational,https://clinicaltrials.gov/show/NCT01859169
Cholangiocarcinoma,NCT03377179,RedHill Biopharma Limited,"March 7, 2018",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03377179
Plasma Cell Leukemia,NCT02504359,OHSU Knight Cancer Institute,"July 20, 2015",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT02504359
Hodgkin Lymphoma,NCT02505269,Massachusetts General Hospital,"August 7, 2015",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02505269
Plasma Cell Leukemia,NCT02506959,M.D. Anderson Cancer Center,"September 14, 2015",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02506959
Hodgkin Lymphoma,NCT03843294,Catherine Bollard,"June 24, 2019",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT03843294
Gliosarcoma,NCT03843814,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,August 2014,N/A,Interventional,https://clinicaltrials.gov/show/NCT03843814
Cholangiocarcinoma,NCT04243057,Beijing Tsinghua Chang Gung Hospital,"August 30, 2019",None,Observational [Patient Registry],https://clinicaltrials.gov/show/NCT04243057
Fallopian Tube Cancer,NCT00748527,Cancer Research UK,July 2007,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00748527
Kidney Cancer,NCT00743236,Wake Forest University Health Sciences,August 2008,N/A,Interventional,https://clinicaltrials.gov/show/NCT00743236
Kidney Cancer,NCT00747305,Harry Drabkin,October 2008,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00747305
Mesothelioma,NCT01445392,National Cancer Institute (NCI),"November 14, 2007",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT01445392
Hodgkin Lymphoma,NCT01447056,Baylor College of Medicine,February 2012,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT01447056
Primary Myelofibrosis,NCT01445769,Incyte Corporation,September 2011,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01445769
Leiomyosarcoma,NCT01442662,UNICANCER,September 2011,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01442662
Adrenocortical Carcinoma,NCT00777244,"University of Turin, Italy",April 2008,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00777244
Cholangiocarcinoma,NCT00779454,Vejle Hospital,September 2008,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00779454
Male Breast Cancer,NCT00071942,National Cancer Institute (NCI),October 2003,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00071942
Kidney Cancer,NCT00073879,Baylor College of Medicine,April 2003,N/A,Interventional,https://clinicaltrials.gov/show/NCT00073879
Fallopian Tube Cancer,NCT00075712,Royal College of Obstetricians and Gynecologists,September 2003,Phase 2/Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00075712
Kidney Cancer,NCT00077129,Eastern Cooperative Oncology Group,September 2004,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00077129
Kidney Cancer,NCT00075348,National Institutes of Health Clinical Center (CC),December 2003,None,Observational,https://clinicaltrials.gov/show/NCT00075348
Kidney Cancer,NCT00075660,NCIC Clinical Trials Group,"January 16, 2004",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00075660
Kidney Cancer,NCT00072046,Alliance for Clinical Trials in Oncology,October 2003,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00072046
Fallopian Tube Cancer,NCT00072267,"University Health Network, Toronto",January 2004,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00072267
Mesothelioma,NCT02716272,Intergroupe Francophone de Cancerologie Thoracique,"March 24, 2016",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02716272
Cholangiocarcinoma,NCT02232932,Assistance Publique - H√¥pitaux de Paris,March 2014,N/A,Interventional,https://clinicaltrials.gov/show/NCT02232932
Cholangiocarcinoma,NCT00907413,Weill Medical College of Cornell University,May 2010,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00907413
Kidney Cancer,NCT00900042,Southwest Oncology Group,July 1993,None,Observational,https://clinicaltrials.gov/show/NCT00900042
Fallopian Tube Cancer,NCT00903630,"Masonic Cancer Center, University of Minnesota",April 2009,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00903630
Kidney Cancer,NCT00908739,Case Comprehensive Cancer Center,May 2008,None,Observational,https://clinicaltrials.gov/show/NCT00908739
Kidney Cancer,NCT00900536,Medical Research Council,July 2007,None,Observational,https://clinicaltrials.gov/show/NCT00900536
Thymoma,NCT03193437,Georgetown University,"April 3, 2018",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03193437
Juvenile Myelomonocytic Leukemia,NCT03190915,National Cancer Institute (NCI),"October 6, 2017",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03190915
Primary Myelofibrosis,NCT03194542,Celgene,"November 15, 2017",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03194542
Parathyroid Carcinoma,NCT03280264,"Kyowa Kirin Co., Ltd.","August 30, 2017",Phase 3,Interventional,https://clinicaltrials.gov/show/NCT03280264
Thymoma,NCT03288662,Military Hospital 103,"October 1, 2013",N/A,Interventional,https://clinicaltrials.gov/show/NCT03288662
Kidney Cancer,NCT01497444,Alliance for Clinical Trials in Oncology,May 2012,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT01497444
Fallopian Tube Cancer,NCT01493505,Amgen,January 2012,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT01493505
Male Breast Cancer,NCT01493310,University of Chicago,November 2011,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT01493310
Uveal Melanoma,NCT01430416,Novartis Pharmaceuticals,"December 20, 2011",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT01430416
Cholangiocarcinoma,NCT01439698,Weill Medical College of Cornell University,September 2011,None,Observational [Patient Registry],https://clinicaltrials.gov/show/NCT01439698
Uveal Melanoma,NCT01438658,Hadassah Medical Organization,September 2011,None,Observational,https://clinicaltrials.gov/show/NCT01438658
Cholangiocarcinoma,NCT01439685,Weill Medical College of Cornell University,July 2011,None,Observational,https://clinicaltrials.gov/show/NCT01439685
Juvenile Myelomonocytic Leukemia,NCT01824693,Children's Oncology Group,"June 24, 2013",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01824693
Hodgkin Lymphoma,NCT01820117,St. Jude Children's Research Hospital,"April 26, 2013",None,Observational,https://clinicaltrials.gov/show/NCT01820117
Cholangiocarcinoma,NCT01868490,Siriraj Hospital,"April 17, 2009",Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01868490
Hodgkin Lymphoma,NCT01868451,Memorial Sloan Kettering Cancer Center,May 2013,N/A,Interventional,https://clinicaltrials.gov/show/NCT01868451
Male Breast Cancer,NCT01868503,Stanford University,July 2013,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01868503
Thymoma,NCT03466827,Morten Mau-Soerensen,"October 12, 2017",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03466827
Thymic Carcinoma,NCT03463460,Dwight Owen,"June 19, 2018",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03463460
Fallopian Tube Cancer,NCT00652899,"Masonic Cancer Center, University of Minnesota",March 2008,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00652899
Fallopian Tube Cancer,NCT00653328,Vanderbilt-Ingram Cancer Center,May 2003,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00653328
Kidney Cancer,NCT00656734,Bristol-Myers Squibb,April 2008,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00656734
Mesothelioma,NCT00651456,Intergroupe Francophone de Cancerologie Thoracique,February 2008,Phase 2/Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00651456
Cholangiocarcinoma,NCT00653978,Changhai Hospital,May 2008,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00653978
Kidney Cancer,NCT00704938,National Institutes of Health Clinical Center (CC),June 2008,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00704938
Fallopian Tube Cancer,NCT00702299,University of Arizona,September 2007,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00702299
Mesothelioma,NCT01604005,Brynn Chappell,July 2012,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT01604005
Cholangiocarcinoma,NCT04256980,Innovent Biologics (Suzhou) Co. Ltd.,"March 3, 2020",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04256980
Cholangiocarcinoma,NCT04306367,Georgetown University,"April 1, 2020",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04306367
Cholangiocarcinoma,NCT04304781,Danielle Kim Turgeon,October 2020,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT04304781
Cholangiocarcinoma,NCT04301999,First People's Hospital of Hangzhou,"March 1, 2020",N/A,Interventional,https://clinicaltrials.gov/show/NCT04301999
Fallopian Tube Cancer,NCT00562640,Memorial Sloan Kettering Cancer Center,October 2007,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00562640
Adrenocortical Carcinoma,NCT00568139,University of Wuerzburg,January 2008,None,Observational,https://clinicaltrials.gov/show/NCT00568139
Fallopian Tube Cancer,NCT00569673,Gynecologic Oncology Group,March 2008,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00569673
Pleuropulmonary Blastoma,NCT00565903,"D. Ashley Hill, M.D.",March 2005,None,Observational,https://clinicaltrials.gov/show/NCT00565903
T-Cell Lymphoma,NCT03021057,The University of Hong Kong,"December 1, 2016",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03021057
Uveal Melanoma,NCT03022565,University of Miami,January 2020,Early Phase 1,Interventional,https://clinicaltrials.gov/show/NCT03022565
Gliosarcoma,NCT03020602,Seema Nagpal,"January 4, 2017",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT03020602
Gliosarcoma,NCT03020017,Northwestern University,"May 25, 2017",Early Phase 1,Interventional,https://clinicaltrials.gov/show/NCT03020017
Hodgkin Lymphoma,NCT02115126,"David Rizzieri, MD",December 2016,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02115126
Adrenocortical Carcinoma,NCT00457587,University of Wuerzburg,September 2005,None,Observational [Patient Registry],https://clinicaltrials.gov/show/NCT00457587
Fallopian Tube Cancer,NCT00459290,Gynecologic Oncology Group,May 2007,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00459290
Adrenocortical Carcinoma,NCT00453674,University of Wuerzburg,January 2003,None,Observational,https://clinicaltrials.gov/show/NCT00453674
Kidney Cancer,NCT00459875,Memorial Sloan Kettering Cancer Center,March 2007,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00459875
Pheochromocytoma,NCT00458952,"Molecular Insight Pharmaceuticals, Inc.",April 2007,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00458952
Kidney Cancer,NCT00459979,Case Comprehensive Cancer Center,March 2007,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00459979
Uveal Melanoma,NCT00459849,Barnes Retina Institute,July 2000,N/A,Interventional,https://clinicaltrials.gov/show/NCT00459849
Kidney Cancer,NCT00458484,Case Comprehensive Cancer Center,"February 20, 2007",N/A,Interventional,https://clinicaltrials.gov/show/NCT00458484
Adrenocortical Carcinoma,NCT00453895,University of Wuerzburg,July 2007,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00453895
Cholangiocarcinoma,NCT03603834,Khon Kaen University,"September 19, 2018",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03603834
Mucosal Melanoma,NCT03602547,AnewPharma,"July 31, 2018",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03602547
Hodgkin Lymphoma,NCT03602131,Sichuan University,"January 1, 2019",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03602131
Kidney Cancer,NCT01894607,M.D. Anderson Cancer Center,October 2013,N/A,Interventional,https://clinicaltrials.gov/show/NCT01894607
Adrenocortical Carcinoma,NCT01898715,"Millendo Therapeutics, Inc.","August 13, 2013",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT01898715
Pancreatic Neuroendocrine Tumor,NCT03741517,Uppsala University,"January 30, 2019",None,Observational [Patient Registry],https://clinicaltrials.gov/show/NCT03741517
Fallopian Tube Cancer,NCT00014690,AstraZeneca,March 2001,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00014690
Kidney Cancer,NCT00016939,Southwest Oncology Group,May 2001,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00016939
Kidney Cancer,NCT00019955,National Cancer Institute (NCI),March 2000,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00019955
Fallopian Tube Cancer,NCT00019552,National Cancer Institute (NCI),September 1998,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00019552
Kidney Cancer,NCT00012337,Memorial Sloan Kettering Cancer Center,January 2001,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00012337
Kidney Cancer,NCT00014183,"University of Maryland, Baltimore",January 2001,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00014183
Fallopian Tube Cancer,NCT00017017,Memorial Sloan Kettering Cancer Center,February 2001,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00017017
Kidney Cancer,NCT00014131,"Caladrius Biosciences, Inc.",November 2001,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00014131
Primary Myelofibrosis,NCT00015821,National Cancer Institute (NCI),May 2000,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00015821
Kidney Cancer,NCT00017329,Memorial Sloan Kettering Cancer Center,April 2001,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00017329
Fallopian Tube Cancer,NCT00019461,National Cancer Institute (NCI),April 1998,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00019461
Male Breast Cancer,NCT00017394,National Cancer Institute (NCI),March 2001,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00017394
Kidney Cancer,NCT00018941,National Cancer Institute (NCI),April 1991,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00018941
Kidney Cancer,NCT00011973,Barbara Ann Karmanos Cancer Institute,December 2000,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00011973
Fallopian Tube Cancer,NCT00012090,Memorial Sloan Kettering Cancer Center,September 2000,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00012090
Thymoma,NCT00010257,Eastern Cooperative Oncology Group,February 2001,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00010257
Fallopian Tube Cancer,NCT00010179,NCIC Clinical Trials Group,"October 31, 2000",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00010179
Wilms' Tumor,NCT00011414,National Cancer Institute (NCI),"February 15, 2001",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00011414
Hodgkin Lymphoma,NCT00013533,National Cancer Institute (NCI),"March 14, 2001",Early Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00013533
Fallopian Tube Cancer,NCT00390234,National Cancer Institute (NCI),September 2006,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00390234
Kidney Cancer,NCT00392821,"SCRI Development Innovations, LLC",December 2006,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00392821
Waldenstr√∂m's Macroglobulinemia,NCT00398710,AEterna Zentaris,October 2006,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00398710
Hodgkin Lymphoma,NCT00392314,Rambam Health Care Campus,October 2006,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00392314
Hodgkin Lymphoma,NCT02684292,Merck Sharp & Dohme Corp.,"May 23, 2016",Phase 3,Interventional,https://clinicaltrials.gov/show/NCT02684292
Waldenstr√∂m's Macroglobulinemia,NCT03697356,Kosin University Gospel Hospital,"March 6, 2019",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03697356
Adenoid Cystic Carcinoma,NCT03691207,"Ayala Pharmaceuticals, Inc,","December 14, 2018",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03691207
Pleuropulmonary Blastoma,NCT01247597,National Cancer Institute (NCI),"February 13, 2011",None,Observational,https://clinicaltrials.gov/show/NCT01247597
Cholangiocarcinoma,NCT01247337,Dorte Nielsen,"February 2, 2011",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01247337
Ependymoma,NCT01247922,OSI Pharmaceuticals,"May 23, 2011",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01247922
Cutaneous T Cell Lymphoma,NCT02192021,"Falo, Louis, MD",January 2016,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT02192021
Hodgkin Lymphoma,NCT02191930,University of Cologne,September 2015,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02191930
Kidney Cancer,NCT03542565,"Ceevra, Inc.","April 30, 2018",N/A,Interventional,https://clinicaltrials.gov/show/NCT03542565
Hodgkin Lymphoma,NCT03540849,"University Hospital, Caen","March 7, 2018",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03540849
Fallopian Tube Cancer,NCT00522301,Memorial Sloan Kettering Cancer Center,July 2007,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00522301
Kidney Cancer,NCT04222374,"University Hospital, Bordeaux","December 10, 2019",None,Observational,https://clinicaltrials.gov/show/NCT04222374
Primary Myelofibrosis,NCT02806375,St. Petersburg State Pavlov Medical University,January 2016,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02806375
Cholangiocarcinoma,NCT04059562,RWTH Aachen University,"April 1, 2020",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04059562
Mesothelioma,NCT04056026,ProgenaBiome,"September 18, 2018",Early Phase 1,Interventional,https://clinicaltrials.gov/show/NCT04056026
Hodgkin Lymphoma,NCT02362997,Dana-Farber Cancer Institute,April 2015,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02362997
Thymic Carcinoma,NCT02364076,Georgetown University,March 2015,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02364076
Primary Myelofibrosis,NCT01790295,John Mascarenhas,November 2013,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01790295
Ependymoma,NCT01795313,"Ian F. Pollack, M.D.",August 2012,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT01795313
Kidney Cancer,NCT03666104,"Ceevra, Inc.","August 21, 2018",N/A,Interventional,https://clinicaltrials.gov/show/NCT03666104
Hodgkin Lymphoma,NCT03664323,Hospices Civils de Lyon,"January 31, 2018",None,Observational,https://clinicaltrials.gov/show/NCT03664323
Kidney Cancer,NCT00100906,H. Lee Moffitt Cancer Center and Research Institute,August 2004,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00100906
Mesothelioma,NCT00101283,Eastern Cooperative Oncology Group,November 2005,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00101283
Hodgkin Lymphoma,NCT01534078,Massachusetts General Hospital,March 2012,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01534078
Mesothelioma,NCT02958683,Heart of England NHS Trust,July 2011,None,Observational,https://clinicaltrials.gov/show/NCT02958683
Kidney Cancer,NCT02950766,"Patrick Ott, MD","March 3, 2019",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT02950766
Hodgkin Lymphoma,NCT02955043,"University of Wisconsin, Madison","December 22, 2016",N/A,Interventional,https://clinicaltrials.gov/show/NCT02955043
Cholangiocarcinoma,NCT04568512,Mahidol University,"January 1, 2016",N/A,Interventional,https://clinicaltrials.gov/show/NCT04568512
Pheochromocytoma,NCT04566406,Jagiellonian University,January 2003,None,Observational,https://clinicaltrials.gov/show/NCT04566406
Hodgkin Lymphoma,NCT01030900,National Cancer Institute (NCI),"October 22, 2009",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01030900
Uveal Melanoma,NCT01034787,AHS Cancer Control Alberta,"August 17, 2009",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01034787
Pheochromocytoma,NCT04320589,"National Cancer Institute, Egypt","June 30, 2019",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04320589
Kidney Cancer,NCT04329767,Intuitive Surgical,"September 18, 2020",None,Observational,https://clinicaltrials.gov/show/NCT04329767
Kidney Cancer,NCT04322955,Mark Stein,March 2020,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04322955
Primary Myelofibrosis,NCT02055781,CTI BioPharma,December 2013,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT02055781
Cholangiocarcinoma,NCT02052778,"Taiho Oncology, Inc.",July 2014,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02052778
Cholangiocarcinoma,NCT03003065,Chinese University of Hong Kong,"March 28, 2014",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03003065
Kidney Cancer,NCT00293501,University of Vermont,December 2005,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00293501
Mesothelioma,NCT00295503,University of Texas Southwestern Medical Center,February 2006,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00295503
Kidney Cancer,NCT00263107,"University of California, Davis",August 2004,None,Observational,https://clinicaltrials.gov/show/NCT00263107
Fallopian Tube Cancer,NCT00263822,European Organisation for Research and Treatment of Cancer - EORTC,September 2005,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00263822
Kidney Cancer,NCT00262886,University of Rochester,August 2001,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00262886
Chondrosarcoma,NCT01182753,Heidelberg University,August 2010,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT01182753
Kidney Cancer,NCT01185366,M.D. Anderson Cancer Center,August 2010,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01185366
Adrenocortical Carcinoma,NCT01514526,Spanish Oncology Genito-Urinary Group,January 2012,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01514526
Mesothelioma,NCT03560973,Gruppo Oncologico Italiano di Ricerca Clinica,"December 22, 2016",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03560973
Kidney Cancer,NCT03568435,Bristol-Myers Squibb,"February 14, 2018",None,Observational,https://clinicaltrials.gov/show/NCT03568435
Leiomyosarcoma,NCT02983539,AC Camargo Cancer Center,October 2015,None,Observational,https://clinicaltrials.gov/show/NCT02983539
Cholangiocarcinoma,NCT03211169,Stanford University,"July 29, 2017",N/A,Interventional,https://clinicaltrials.gov/show/NCT03211169
Kidney Cancer,NCT00118326,Fred Hutchinson Cancer Research Center,August 2003,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00118326
Fallopian Tube Cancer,NCT00112957,Ludwig Institute for Cancer Research,December 2004,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00112957
Fallopian Tube Cancer,NCT00114166,Gynecologic Oncology Group,January 2005,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00114166
Male Breast Cancer,NCT00119262,National Cancer Institute (NCI),October 2005,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00119262
Mucosal Melanoma,NCT00110019,National Cancer Institute (NCI),June 2005,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00110019
Thymoma,NCT01621568,National Cancer Institute (NCI),"May 15, 2012",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01621568
Mesothelioma,NCT01627795,Oshadi Drug Administration,December 2016,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01627795
Mesothelioma,NCT03531840,National Cancer Institute (NCI),"July 11, 2018",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03531840
Kidney Cancer,NCT03534206,"Ceevra, Inc.","April 11, 2018",N/A,Interventional,https://clinicaltrials.gov/show/NCT03534206
Thymic Carcinoma,NCT01011439,"Tiziana Life Sciences, PLC","February 22, 2010",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01011439
Kidney Cancer,NCT00025376,University of Chicago,October 2001,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00025376
Fallopian Tube Cancer,NCT00028912,Memorial Sloan Kettering Cancer Center,November 2001,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00028912
Pheochromocytoma,NCT00028106,Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),"December 5, 2001",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00028106
Male Breast Cancer,NCT00028535,National Cancer Institute (NCI),November 2001,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00028535
Fallopian Tube Cancer,NCT00021034,Memorial Sloan Kettering Cancer Center,March 2001,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00021034
Kidney Cancer,NCT00021021,Ribozyome,September 2001,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00021021
Kidney Cancer,NCT00024388,Theradex,April 2001,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00024388
Juvenile Myelomonocytic Leukemia,NCT00025038,National Cancer Institute (NCI),June 2001,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00025038
Kidney Cancer,NCT00027573,Alliance for Clinical Trials in Oncology,October 2001,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00027573
Kaposi's Sarcoma,NCT00026793,National Cancer Institute (NCI),"April 23, 2001",None,Observational,https://clinicaltrials.gov/show/NCT00026793
Fallopian Tube Cancer,NCT00022347,Memorial Sloan Kettering Cancer Center,May 2001,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00022347
Kidney Cancer,NCT00025103,Children's Cancer and Leukaemia Group,May 2001,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00025103
Kidney Cancer,NCT00027664,Cancer Research UK,February 2001,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00027664
Male Breast Cancer,NCT00024154,National Cancer Institute (NCI),February 2002,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00024154
Kidney Cancer,NCT00025519,Fox Chase Cancer Center,June 2001,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00025519
Kaposi's Sarcoma,NCT00026728,National Cancer Institute (NCI),February 2001,None,Observational,https://clinicaltrials.gov/show/NCT00026728
Fallopian Tube Cancer,NCT00028743,NCIC Clinical Trials Group,"August 31, 2001",Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00028743
Kidney Cancer,NCT00020540,National Cancer Institute (NCI),March 2001,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00020540
HODGKIN LYMPHOMA,NCT00795613,Ospedale Santa Croce-Carle Cuneo,June 2008,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00795613
Cholangiocarcinoma,NCT00797121,Sun Yat-sen University,May 2008,Phase 4,Interventional,https://clinicaltrials.gov/show/NCT00797121
Mesothelioma,NCT00794859,King's College London,October 2008,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00794859
Cutaneous T Cell Lymphoma,NCT01663571,NYU Langone Health,"May 1, 2012",None,Observational,https://clinicaltrials.gov/show/NCT01663571
Kidney Cancer,NCT00967577,Weill Medical College of Cornell University,July 2009,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00967577
Thymoma,NCT00965250,National Cancer Institute (NCI),August 2009,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00965250
Thymoma,NCT00965627,Istituto Clinico Humanitas,June 2008,None,Observational,https://clinicaltrials.gov/show/NCT00965627
Hodgkin Lymphoma,NCT04026269,Han weidong,"July 30, 2019",Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04026269
Kidney Cancer,NCT04021238,UNC Lineberger Comprehensive Cancer Center,"October 7, 2020",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04021238
Cutaneous T Cell Lymphoma,NCT03385226,"University College, London","January 15, 2019",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03385226
Plasma Cell Leukemia,NCT03389347,University of Washington,"February 14, 2018",N/A,Interventional,https://clinicaltrials.gov/show/NCT03389347
Dermatofibrosarcoma Protuberans,NCT03381846,Mayo Clinic,"July 1, 2018",N/A,Interventional,https://clinicaltrials.gov/show/NCT03381846
Pleuropulmonary Blastoma,NCT03382158,Children's Hospitals and Clinics of Minnesota,"December 6, 2016",None,Observational,https://clinicaltrials.gov/show/NCT03382158
Hodgkin Lymphoma,NCT03383965,"Immune Cell, Inc.","March 1, 2017",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT03383965
Mesothelioma,NCT01362790,National Cancer Institute (NCI),"May 11, 2011",Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01362790
Thymoma,NCT01364727,Heather Wakelee,June 2011,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01364727
Cholangiocarcinoma,NCT01912053,Center Eugene Marquis,September 2013,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01912053
Ependymoma,NCT01295944,National Cancer Institute (NCI),"December 3, 2015",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01295944
Primary Myelofibrosis,NCT01298934,Ronald Hoffman,September 2009,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01298934
Fallopian Tube Cancer,NCT00803569,Ludwig Institute for Cancer Research,"November 14, 2008",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00803569
Kidney Cancer,NCT00806650,City of Hope Medical Center,July 2008,None,Observational,https://clinicaltrials.gov/show/NCT00806650
T-Cell Lymphoma,NCT04331119,Washington University School of Medicine,"July 23, 2020",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04331119
Mesothelioma,NCT04334759,"PrECOG, LLC.",November 2020,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT04334759
Kidney Cancer,NCT04337970,Memorial Sloan Kettering Cancer Center,"April 6, 2020",Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04337970
Alveolar Soft Part Sarcoma,NCT03016819,"Advenchen Laboratories, LLC","August 15, 2017",Phase 3,Interventional,https://clinicaltrials.gov/show/NCT03016819
Adrenocortical Carcinoma,NCT04358107,National Cancer Institute (NCI),"November 23, 2020",None,Observational,https://clinicaltrials.gov/show/NCT04358107
Cholangiocarcinoma,NCT02665494,Fondazione del Piemonte per l'Oncologia,January 2016,None,Observational,https://clinicaltrials.gov/show/NCT02665494
Adenoid Cystic Carcinoma,NCT02662608,M.D. Anderson Cancer Center,"December 29, 2015",N/A,Interventional,https://clinicaltrials.gov/show/NCT02662608
Hodgkin Lymphoma,NCT02665650,Affimed GmbH,May 2016,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT02665650
T-cell Lymphoma,NCT04234048,"SciTech Development, LLC",July 2020,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT04234048
Hodgkin Lymphoma,NCT04233294,Chinese PLA General Hospital,"February 2, 2020",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04233294
Penile Cancer,NCT04231981,MedSIR,"April 28, 2020",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04231981
Cholangiocarcinoma,NCT04238715,"Eisai Co., Ltd.","January 22, 2020",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04238715
Hodgkin Lymphoma,NCT04239170,Peking University,January 2020,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04239170
Kidney Cancer,NCT00316901,National Institutes of Health Clinical Center (CC),April 2006,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00316901
Thymic Carcinoma,NCT00314873,Indiana University School of Medicine,April 2006,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00314873
Kidney Cancer,NCT00311545,Southwest Oncology Group,None,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00311545
Kidney Cancer,NCT00126178,Agenus Inc.,May 2005,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00126178
Fallopian Tube Cancer,NCT00126542,National Cancer Institute (NCI),April 2005,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00126542
Mesothelioma,NCT00128102,Merck Sharp & Dohme Corp.,"June 30, 2005",Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00128102
Pheochromocytoma,NCT00126412,GE Healthcare,"August 2, 2005",Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00126412
Ependymoma,NCT01088035,Ann & Robert H Lurie Children's Hospital of Chicago,April 2010,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01088035
Male Breast Cancer,NCT01084057,City of Hope Medical Center,"May 17, 2010",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT01084057
Kidney Cancer,NCT03804320,IRCCS San Raffaele,"April 29, 2015",N/A,Interventional,https://clinicaltrials.gov/show/NCT03804320
Hodgkin Lymphoma,NCT03407144,Merck Sharp & Dohme Corp.,"April 9, 2018",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03407144
Uveal Melanoma,NCT03408587,Viralytics,"January 29, 2018",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT03408587
Cholangiocarcinoma,NCT00604266,University of Toronto,August 2007,None,Observational,https://clinicaltrials.gov/show/NCT00604266
Mesothelioma,NCT00604461,H. Lee Moffitt Cancer Center and Research Institute,October 2007,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00604461
Hodgkin Lymphoma,NCT00606645,"Xencor, Inc.",December 2007,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00606645
Kidney Cancer,NCT00601926,Paul Monk,February 2008,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00601926
Fallopian Tube Cancer,NCT01281254,Amgen,"April 18, 2011",Phase 3,Interventional,https://clinicaltrials.gov/show/NCT01281254
Fallopian Tube Cancer,NCT01281514,Fox Chase Cancer Center,"December 14, 2010",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT01281514
Mesothelioma,NCT01281800,Institute of Oncology Ljubljana,August 2008,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01281800
Hodgkin Lymphoma,NCT01764230,Masaryk University,January 2004,N/A,Interventional,https://clinicaltrials.gov/show/NCT01764230
Uveal Melanoma,NCT00811200,Leiden University Medical Center,September 2009,Phase 2/Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00811200
Thymoma,NCT00818090,Korean Cancer Study Group,September 2008,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00818090
Kidney Cancer,NCT00814021,Institut Claudius Regaud,April 2009,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00814021
Mesothelioma,NCT02467426,Medias Klinikum for Surgical Oncology,September 2009,None,Observational,https://clinicaltrials.gov/show/NCT02467426
Mesothelioma,NCT02464904,Mayo Clinic,July 2015,N/A,Interventional,https://clinicaltrials.gov/show/NCT02464904
Mesothelioma,NCT03207347,University of Florida,"August 13, 2018",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03207347
T-cell Lymphoma,NCT03207789,Grupo de Estudos Multicentricos em Onco-Hematologia,"January 1, 2015",None,Observational [Patient Registry],https://clinicaltrials.gov/show/NCT03207789
Pheochromocytoma,NCT03206060,National Cancer Institute (NCI),"October 10, 2017",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03206060
Pancreatic Neuroendocrine Tumor,NCT03204019,Chinese Academy of Medical Sciences,October 2016,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03204019
Primary Myelofibrosis,NCT01773187,CTI BioPharma,January 2013,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT01773187
Kidney Cancer,NCT01775930,M.D. Anderson Cancer Center,October 2013,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01775930
Kidney Cancer,NCT00425386,OHSU Knight Cancer Institute,August 2006,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00425386
Male Breast Cancer,NCT00425672,University of Washington,September 2005,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00425672
Mucosal Melanoma,NCT00424515,Dana-Farber Cancer Institute,July 2006,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00424515
Fallopian Tube Cancer,NCT00429793,National Cancer Institute (NCI),February 2007,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00429793
Kaposi's Sarcoma,NCT00339326,National Cancer Institute (NCI),"September 1, 2002",None,Observational,https://clinicaltrials.gov/show/NCT00339326
Pheochromocytoma,NCT00339131,"Molecular Insight Pharmaceuticals, Inc.",June 2006,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00339131
Fallopian Tube Cancer,NCT00334893,National Cancer Institute (NCI),April 2006,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00334893
Kidney Cancer,NCT00331409,OHSU Knight Cancer Institute,January 2006,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00331409
Fallopian Tube Cancer,NCT00331422,"Masonic Cancer Center, University of Minnesota",October 2005,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00331422
Thymoma,NCT00332969,Novartis Pharmaceuticals,September 2005,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00332969
Kidney Cancer,NCT03421418,"Ceevra, Inc.","January 9, 2018",N/A,Interventional,https://clinicaltrials.gov/show/NCT03421418
Primary Myelofibrosis,NCT03426969,M.D. Anderson Cancer Center,"January 31, 2018",Early Phase 1,Interventional,https://clinicaltrials.gov/show/NCT03426969
Cutaneous T Cell Lymphoma,NCT00221039,M.D. Anderson Cancer Center,"April 2, 2004",Phase 4,Interventional,https://clinicaltrials.gov/show/NCT00221039
Uveal Melanoma,NCT02223819,Columbia University,March 2015,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02223819
Hodgkin Lymphoma,NCT02227433,Fondazione Italiana Linfomi ONLUS,"February 4, 2013",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02227433
Thymoma,NCT02220855,Patrick Joseph Loehrer Sr.,"October 1, 2014",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02220855
Mesothelioma,NCT02798536,National Cancer Institute (NCI),"July 27, 2016",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT02798536
Hodgkin Lymphoma,NCT02795013,St. Jude Children's Research Hospital,"August 17, 2016",None,Observational,https://clinicaltrials.gov/show/NCT02795013
Male Breast Cancer,NCT01720602,University of Washington,November 2012,N/A,Interventional,https://clinicaltrials.gov/show/NCT01720602
Plasma Cell Leukemia,NCT01729091,M.D. Anderson Cancer Center,"June 10, 2013",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01729091
Thymoma,NCT04162691,Zhejiang Cancer Hospital,"November 6, 2019",None,Observational,https://clinicaltrials.gov/show/NCT04162691
Kidney Cancer,NCT04162834,Asan Medical Center,"November 21, 2019",Phase 4,Interventional,https://clinicaltrials.gov/show/NCT04162834
Cholangiocarcinoma,NCT02548195,Shanghai Zhongshan Hospital,July 2015,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT02548195
Cutaneous T Cell Lymphoma,NCT02546440,Universit√§tsmedizin Mannheim,September 2015,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02546440
Plasma Cell Leukemia,NCT02547662,Mayo Clinic,"December 24, 2015",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02547662
Thymic Carcinoma,NCT03583086,Vanderbilt-Ingram Cancer Center,"July 10, 2018",Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03583086
Hodgkin Lymphoma,NCT03580408,The Lymphoma Academic Research Organisation,"August 31, 2018",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03580408
Cholangiocarcinoma,NCT03820310,"Newish Technology (Beijing) Co., Ltd.","May 1, 2018",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03820310
T-cell Lymphoma,NCT03829540,Stony Brook University,"June 18, 2019",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT03829540
Kidney Cancer,NCT03824808,University of Missouri-Columbia,"February 26, 2019",Phase 4,Interventional,https://clinicaltrials.gov/show/NCT03824808
Cholangiocarcinoma,NCT02520141,M.D. Anderson Cancer Center,"December 29, 2015",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02520141
Cholangiocarcinoma,NCT01303159,Weill Medical College of Cornell University,March 2010,N/A,Interventional,https://clinicaltrials.gov/show/NCT01303159
Angiosarcoma,NCT01303497,Centre Oscar Lambret,"September 10, 2010",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01303497
Kidney Cancer,NCT03292549,"University Hospital, Bordeaux",April 2014,None,Observational,https://clinicaltrials.gov/show/NCT03292549
Cutaneous T Cell Lymphoma,NCT03292406,Galderma R&D,"December 19, 2017",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03292406
Kidney Cancer,NCT03293563,"University Hospital, Bordeaux",December 2011,None,Observational,https://clinicaltrials.gov/show/NCT03293563
Thymoma,NCT03295227,M.D. Anderson Cancer Center,"December 6, 2017",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT03295227
Hodgkin Lymphoma,NCT04373083,Regeneron Pharmaceuticals,"November 15, 2020",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04373083
Adrenocortical Carcinoma,NCT04373265,Corcept Therapeutics,"September 30, 2020",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT04373265
Primary Myelofibrosis,NCT04370301,Fred Hutchinson Cancer Research Center,"December 9, 2020",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04370301
Hodgkin Lymphoma,NCT03968250,University of Leipzig,"August 20, 2018",N/A,Interventional,https://clinicaltrials.gov/show/NCT03968250
Uveal Melanoma,NCT03964298,Institut Curie,November 2016,None,Observational,https://clinicaltrials.gov/show/NCT03964298
Pancreatic Neuroendocrine Tumor,NCT03967951,Francesco De Cobelli,"March 23, 2019",None,Observational,https://clinicaltrials.gov/show/NCT03967951
Hodgkin Lymphoma,NCT01251107,Fondazione Michelangelo,March 2000,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT01251107
Cholangiocarcinoma,NCT01253148,H. Lee Moffitt Cancer Center and Research Institute,January 2011,N/A,Interventional,https://clinicaltrials.gov/show/NCT01253148
Uveal Melanoma,NCT01252251,Memorial Sloan Kettering Cancer Center,November 2010,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01252251
Kaposi's Sarcoma,NCT02029430,CytRx,January 2014,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02029430
Mesothelioma,NCT02029105,Eskisehir Osmangazi University,January 2004,None,Observational,https://clinicaltrials.gov/show/NCT02029105
Kidney Cancer,NCT04120805,University of Chicago,"January 1, 2016",N/A,Interventional,https://clinicaltrials.gov/show/NCT04120805
Adrenocortical Carcinoma,NCT01048892,Children's Oncology Group,September 2009,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT01048892
Male Breast Cancer,NCT01042535,H. Lee Moffitt Cancer Center and Research Institute,"December 28, 2009",Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01042535
Cholangiocarcinoma,NCT01043172,"National Cancer Center, Korea","July 20, 2009",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01043172
Penile Cancer,NCT04475016,Sun Yat-sen University,"August 12, 2020",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04475016
Kidney Cancer,NCT04472663,Bristol-Myers Squibb,"June 14, 2019",None,Observational,https://clinicaltrials.gov/show/NCT04472663
Mucosal Melanoma,NCT04472806,Fudan University,"June 20, 2020",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04472806
Primary Myelofibrosis,NCT01371617,"Infinity Pharmaceuticals, Inc.",October 2011,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01371617
Plasma Cell Leukemia,NCT01372540,M.D. Anderson Cancer Center,"February 24, 2012",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT01372540
Pheochromocytoma,NCT01377532,"University of California, San Francisco",None,None,Expanded Access,https://clinicaltrials.gov/show/NCT01377532
Uveal Melanoma,NCT01377025,Prof. Dr. med. Max. E. Scheulen,June 2011,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01377025
Pheochromocytoma,NCT01379898,University Medical Center Groningen,December 2011,Phase 4,Interventional,https://clinicaltrials.gov/show/NCT01379898
Pheochromocytoma,NCT01373736,Vancouver Coastal Health,None,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT01373736
Hodgkin Lymphoma,NCT03331731,"Peter MacCallum Cancer Centre, Australia","November 29, 2018",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03331731
Kidney Cancer,NCT03334344,"Ceevra, Inc.","October 24, 2017",N/A,Interventional,https://clinicaltrials.gov/show/NCT03334344
Angiosarcoma,NCT03331250,Massachusetts General Hospital,"January 18, 2018",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03331250
Hodgkin Lymphoma,NCT03337919,"University College, London","December 3, 2018",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03337919
Primary Myelofibrosis,NCT03895112,John Mascarenhas,"February 15, 2019",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT03895112
Leiomyosarcoma,NCT03526679,National Taiwan University Hospital,"July 12, 2018",Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03526679
Fallopian Tube Cancer,NCT00897039,Southeastern Gynecologic Oncology,March 2006,None,Observational,https://clinicaltrials.gov/show/NCT00897039
T-cell Lymphoma,NCT00893516,Emergent BioSolutions,May 2007,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00893516
Mesothelioma,NCT00895648,"University Health Network, Toronto",January 2009,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00895648
Kidney Cancer,NCT00899860,Wake Forest University Health Sciences,September 2003,None,Observational,https://clinicaltrials.gov/show/NCT00899860
Cholangiocarcinoma,NCT00630890,"University of California, San Francisco",October 2007,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00630890
Cholangiocarcinoma,NCT04415190,"Central Hospital, Nancy, France","June 1, 2020",None,Observational,https://clinicaltrials.gov/show/NCT04415190
Hodgkin Lymphoma,NCT04419441,Ospedale Maggiore Di Trieste,"June 24, 2020",None,Observational,https://clinicaltrials.gov/show/NCT04419441
Uveal Melanoma,NCT04417530,Aura Biosciences,"August 5, 2020",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04417530
Kidney Cancer,NCT04415697,Barretos Cancer Hospital,"January 2, 2019",None,Observational,https://clinicaltrials.gov/show/NCT04415697
Hodgkin Lymphoma,NCT01056679,University of Cologne,April 2010,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT01056679
T-Cell Lymphoma,NCT01878708,Dana-Farber Cancer Institute,July 2013,Early Phase 1,Interventional,https://clinicaltrials.gov/show/NCT01878708
Cutaneous T Cell Lymphoma,NCT01676831,Abramson Cancer Center of the University of Pennsylvania,February 2012,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01676831
Cholangiocarcinoma,NCT01673802,University of Alabama at Birmingham,August 2012,Early Phase 1,Interventional,https://clinicaltrials.gov/show/NCT01673802
Fallopian Tube Cancer,NCT01670799,New Mexico Cancer Care Alliance,March 2012,Early Phase 1,Interventional,https://clinicaltrials.gov/show/NCT01670799
Hodgkin Lymphoma,NCT01393106,Gilead Sciences,September 2011,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01393106
Cholangiocarcinoma,NCT01392274,Mauna Kea Technologies,April 2012,None,Observational,https://clinicaltrials.gov/show/NCT01392274
Kidney Cancer,NCT01392183,M.D. Anderson Cancer Center,"October 24, 2012",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01392183
Cholangiocarcinoma,NCT01522573,Weill Medical College of Cornell University,November 2011,None,Observational,https://clinicaltrials.gov/show/NCT01522573
Cholangiocarcinoma,NCT01525069,Washington University School of Medicine,"April 3, 2012",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT01525069
Adrenocortical Carcinoma,NCT01528956,Children's Oncology Group,February 2012,None,Observational,https://clinicaltrials.gov/show/NCT01528956
Mesothelioma,NCT01521325,Morphotek,September 2011,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT01521325
Adenoid Cystic Carcinoma,NCT01524692,University of Virginia,March 2012,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01524692
Hodgkin Lymphoma,NCT01523847,Fondazione Italiana Linfomi ONLUS,November 2010,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01523847
Cholangiocarcinoma,NCT01525719,Ratchavithi Hospital,January 2012,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01525719
Penile Cancer,NCT00512096,M.D. Anderson Cancer Center,August 1999,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00512096
Kidney Cancer,NCT00514215,Barbara Ann Karmanos Cancer Institute,January 2006,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00514215
Hodgkin Lymphoma,NCT00512980,University of Cologne,August 2008,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00512980
Kidney Cancer,NCT00365768,Columbia University,October 2004,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00365768
Fallopian Tube Cancer,NCT00369954,Gynecologic Oncology Group,April 2006,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00369954
Kidney Cancer,NCT00369564,University of South Florida,May 2007,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00369564
Male Breast Cancer,NCT00368875,National Cancer Institute (NCI),July 2006,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00368875
Hodgkin Lymphoma,NCT01990534,"Millennium Pharmaceuticals, Inc.","March 14, 2014",Phase 4,Interventional,https://clinicaltrials.gov/show/NCT01990534
Mesothelioma,NCT02592551,Baylor College of Medicine,May 2016,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02592551
Cholangiocarcinoma,NCT02592538,First People's Hospital of Hangzhou,December 2015,N/A,Interventional,https://clinicaltrials.gov/show/NCT02592538
Fallopian Tube Cancer,NCT03924245,Vanderbilt-Ingram Cancer Center,"September 18, 2019",Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03924245
Thymic Carcinoma,NCT03921671,Marina Garassino,"November 1, 2018",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03921671
Uveal Melanoma,NCT03922880,Memorial Sloan Kettering Cancer Center,"April 16, 2019",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT03922880
Hodgkin Lymphoma,NCT03923504,Virginia Commonwealth University,"May 10, 2019",N/A,Interventional,https://clinicaltrials.gov/show/NCT03923504
Hodgkin Lymphoma,NCT03925935,Angiocrine Bioscience,"May 7, 2019",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT03925935
Hodgkin Lymphoma,NCT00850200,University of Florida,August 2009,N/A,Interventional,https://clinicaltrials.gov/show/NCT00850200
Kidney Cancer,NCT00853021,"Jorge A. Garcia, MD",December 2005,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00853021
Kidney Cancer,NCT00853125,"Rutgers, The State University of New Jersey",February 2009,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00853125
Mesothelioma,NCT00859469,Columbia University,April 2004,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00859469
Leiomyosarcoma,NCT00856050,Dana-Farber Cancer Institute,February 2009,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00856050
Cholangiocarcinoma,NCT04076761,Sunnybrook Health Sciences Centre,"December 11, 2019",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04076761
Fallopian Tube Cancer,NCT00217529,Fred Hutchinson Cancer Research Center,June 2004,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00217529
Fallopian Tube Cancer,NCT00217555,Fred Hutchinson Cancer Research Center,July 2002,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00217555
Parathyroid Carcinoma,NCT01460030,"Kyowa Kirin Co., Ltd.",November 2011,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT01460030
Pleuropulmonary Blastoma,NCT01464606,Children's Hospitals and Clinics of Minnesota,"December 22, 2009",N/A,Interventional,https://clinicaltrials.gov/show/NCT01464606
Cutaneous T Cell Lymphoma,NCT01460914,Dartmouth-Hitchcock Medical Center,October 2011,None,Observational,https://clinicaltrials.gov/show/NCT01460914
Hodgkin Lymphoma,NCT03159897,Fondazione Italiana Linfomi ONLUS,"August 1, 2017",Phase 3,Interventional,https://clinicaltrials.gov/show/NCT03159897
Pheochromocytoma,NCT03158870,Hospices Civils de Lyon,July 2017,None,Observational,https://clinicaltrials.gov/show/NCT03158870
T-Cell Lymphoma,NCT00161590,Weill Medical College of Cornell University,July 2004,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00161590
T-Cell Lymphoma,NCT00161239,University of Medicine and Dentistry of New Jersey,February 2005,N/A,Interventional,https://clinicaltrials.gov/show/NCT00161239
Juvenile Myelomonocytic Leukemia,NCT00167219,"Masonic Cancer Center, University of Minnesota","November 18, 1999",Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00167219
Kidney Cancer,NCT01542333,Children's Oncology Group,February 2012,None,Observational,https://clinicaltrials.gov/show/NCT01542333
Kidney Cancer,NCT01544569,Children's Oncology Group,March 2012,None,Observational,https://clinicaltrials.gov/show/NCT01544569
Adrenocortical Carcinoma,NCT00924989,Astellas Pharma Inc,"December 1, 2009",Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00924989
Uveal Melanoma,NCT00929019,Radboud University,June 2009,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00929019
Chondrosarcoma,NCT00543712,"Genentech, Inc.",June 2007,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00543712
Kidney Cancer,NCT00541008,UNICANCER,September 2007,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00541008
Uveal Melanoma,NCT00540930,"Shields, Shields and Associates",April 2007,Phase 4,Interventional,https://clinicaltrials.gov/show/NCT00540930
T-Cell Lymphoma,NCT00542919,Eli Lilly and Company,November 2007,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00542919
Kidney Cancer,NCT00540969,Alliance for Clinical Trials in Oncology,February 2008,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00540969
Cholangiocarcinoma,NCT00540735,"University Hospital, Angers",April 2008,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00540735
Hodgkin Lymphoma,NCT00543582,Mirati Therapeutics Inc.,October 2007,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00543582
Fallopian Tube Cancer,NCT01100372,Medical University Innsbruck,July 2009,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01100372
Kidney Cancer,NCT01105364,"National Cancer Institute, France",December 2007,N/A,Interventional,https://clinicaltrials.gov/show/NCT01105364
Thymoma,NCT01100944,National Cancer Institute (NCI),"March 4, 2010",Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01100944
Uveal Melanoma,NCT01801358,"Array Biopharma, now a wholly owned subsidiary of Pfizer",August 2013,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01801358
Hepatosplenic T-Cell Lymphoma,NCT01804166,"Janssen Scientific Affairs, LLC","March 21, 2013",Phase 4,Interventional,https://clinicaltrials.gov/show/NCT01804166
Adrenocortical Carcinoma,NCT04447014,National Cancer Institute (NCI),"June 25, 2020",None,Observational,https://clinicaltrials.gov/show/NCT04447014
Primary Myelofibrosis,NCT04446650,Celgene,"June 30, 2020",Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT04446650
Mucosal Melanoma,NCT03986515,Henan Cancer Hospital,"June 4, 2019",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03986515
Fallopian Tube Cancer,NCT00538031,City of Hope Medical Center,"December 22, 2003",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00538031
Hypopharyngeal Cancer,NCT04502641,Sun Yat-sen University,"August 1, 2020",Phase 3,Interventional,https://clinicaltrials.gov/show/NCT04502641
Kidney Cancer,NCT04508725,Stanford University,"August 15, 2020",N/A,Interventional,https://clinicaltrials.gov/show/NCT04508725
Kaposi's Sarcoma,NCT01276236,"University of California, San Francisco",February 2011,N/A,Interventional,https://clinicaltrials.gov/show/NCT01276236
Mesothelioma,NCT02610140,Bayer,"December 3, 2015",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02610140
Mesothelioma,NCT02613299,Mayo Clinic,November 2015,None,Observational,https://clinicaltrials.gov/show/NCT02613299
Mesothelioma,NCT02613312,Mayo Clinic,"March 18, 2016",None,Observational,https://clinicaltrials.gov/show/NCT02613312
Fallopian Tube Cancer,NCT00052468,AGO Study Group,August 2002,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00052468
Kaposi's Sarcoma,NCT00055237,National Cancer Institute (NCI),"February 26, 2003",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00055237
Fallopian Tube Cancer,NCT00053833,Southwest Oncology Group,April 2003,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00053833
Kidney Cancer,NCT00053807,European Organisation for Research and Treatment of Cancer - EORTC,February 1998,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00053807
Kidney Cancer,NCT00057889,National Institutes of Health Clinical Center (CC),February 2003,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00057889
Kidney Cancer,NCT00053820,Medical Research Council,July 2002,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00053820
Kidney Cancer,NCT00058318,Southwest Oncology Group,December 2004,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00058318
Fallopian Tube Cancer,NCT00058435,Memorial Sloan Kettering Cancer Center,December 2002,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00058435
Fallopian Tube Cancer,NCT00055614,Beth Israel Deaconess Medical Center,May 2002,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00055614
Kidney Cancer,NCT00056095,UNICANCER,"November 4, 2002",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00056095
Penile Cancer,NCT00058448,Southwest Oncology Group,October 2004,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00058448
Thymoma,NCT04577495,IRCCS San Raffaele,January 2005,None,Observational,https://clinicaltrials.gov/show/NCT04577495
Pheochromocytoma,NCT04573816,Assistance Publique - H√¥pitaux de Paris,"October 8, 2020",None,Observational,https://clinicaltrials.gov/show/NCT04573816
Hodgkin Lymphoma,NCT02589548,Universidade Federal do Rio de Janeiro,October 2009,None,Observational,https://clinicaltrials.gov/show/NCT02589548
Primary Myelofibrosis,NCT02584777,Baxalta now part of Shire,November 2015,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02584777
Cholangiocarcinoma,NCT02582541,The Second Hospital of Nanjing Medical University,February 2014,N/A,Interventional,https://clinicaltrials.gov/show/NCT02582541
T-cell Lymphoma,NCT02588651,Deepa Jagadeesh,"June 17, 2016",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02588651
Cholangiocarcinoma,NCT02585856,First People's Hospital of Hangzhou,February 2013,N/A,Interventional,https://clinicaltrials.gov/show/NCT02585856
Hodgkin Lymphoma,NCT00736320,University of Cologne,November 2009,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00736320
Cholangiocarcinoma,NCT00733200,Huazhong University of Science and Technology,None,N/A,Interventional,https://clinicaltrials.gov/show/NCT00733200
Hepatosplenic T-cell Lymphoma,NCT00731536,"Centocor Ortho Biotech Services, L.L.C.",October 2008,None,Observational,https://clinicaltrials.gov/show/NCT00731536
Fallopian Tube Cancer,NCT00182767,National Cancer Institute (NCI),January 2006,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00182767
Kidney Cancer,NCT03977571,Frede Donskov,"July 6, 2020",Phase 3,Interventional,https://clinicaltrials.gov/show/NCT03977571
Mesothelioma,NCT04429204,Jonsson Comprehensive Cancer Center,"December 1, 2020",N/A,Interventional,https://clinicaltrials.gov/show/NCT04429204
Uveal Melanoma,NCT04424719,Institut Curie,"June 15, 2020",N/A,Interventional,https://clinicaltrials.gov/show/NCT04424719
Leiomyosarcoma,NCT04420975,Jonsson Comprehensive Cancer Center,"October 14, 2020",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT04420975
Leiomyosarcoma,NCT03773510,Italian Sarcoma Group,"February 28, 2019",Phase 3,Interventional,https://clinicaltrials.gov/show/NCT03773510
Cholangiocarcinoma,NCT03779035,Tianjin Medical University Cancer Institute and Hospital,"December 15, 2018",Phase 3,Interventional,https://clinicaltrials.gov/show/NCT03779035
Fallopian Tube Cancer,NCT03771651,University of Oklahoma,"March 1, 2019",Early Phase 1,Interventional,https://clinicaltrials.gov/show/NCT03771651
Penile Cancer,NCT03774901,Centre Hospitalier Universitaire de Besancon,"March 12, 2019",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03774901
Hodgkin Lymphoma,NCT00145600,St. Jude Children's Research Hospital,"March 2, 2000",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00145600
Hodgkin Lymphoma,NCT03576378,Grupo Espa√±ol de Linfomas y Transplante Aut√≥logo de M√©dula √ìsea,"August 8, 2018",Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03576378
Kidney Cancer,NCT03571438,"University Hospital, Grenoble","October 16, 2017",N/A,Interventional,https://clinicaltrials.gov/show/NCT03571438
Kidney Cancer,NCT01099423,European Organisation for Research and Treatment of Cancer - EORTC,April 2010,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT01099423
Fallopian Tube Cancer,NCT00993655,Canadian Cancer Trials Group,"September 11, 2009",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00993655
Hodgkin Lymphoma,NCT00992030,Fondazione Michelangelo,September 2009,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00992030
Mesothelioma,NCT00996385,Columbia University,September 2009,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00996385
Chondrosarcoma,NCT03173976,"Varun Monga, MD","July 18, 2017",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT03173976
Mucosal Melanoma,NCT03178123,"Shanghai Junshi Bioscience Co., Ltd.","May 31, 2017",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03178123
Hodgkin Lymphoma,NCT03179917,Memorial Sloan Kettering Cancer Center,"June 8, 2017",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03179917
Cholangiocarcinoma,NCT03172832,Medical University of South Carolina,"August 20, 2017",N/A,Interventional,https://clinicaltrials.gov/show/NCT03172832
Pheochromocytoma,NCT03176693,"University of California, Los Angeles","May 5, 2017",Phase 3,Interventional,https://clinicaltrials.gov/show/NCT03176693
Male Breast Cancer,NCT01222377,University of Southern California,September 2010,N/A,Interventional,https://clinicaltrials.gov/show/NCT01222377
Hodgkin Lymphoma,NCT01221571,Affimed GmbH,October 2010,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT01221571
Insulinoma,NCT02560376,Peking Union Medical College Hospital,February 2014,Early Phase 1,Interventional,https://clinicaltrials.gov/show/NCT02560376
Hodgkin Lymphoma,NCT00439361,M.D. Anderson Cancer Center,February 2007,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00439361
Fallopian Tube Cancer,NCT00436501,National Cancer Institute (NCI),January 2007,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00436501
Adrenocortical Carcinoma,NCT00436410,National Institutes of Health Clinical Center (CC),December 2006,Early Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00436410
Cholangiocarcinoma,NCT02128282,"Senhwa Biosciences, Inc.",June 2014,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02128282
Insulinoma,NCT02121366,Guangxi Medical University,March 2014,N/A,Interventional,https://clinicaltrials.gov/show/NCT02121366
Primary Myelofibrosis,NCT02124746,"Sierra Oncology, Inc.","April 30, 2014",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02124746
Ependymoma,NCT02125786,St. Jude Children's Research Hospital,"May 7, 2014",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02125786
Male Breast Cancer,NCT01638247,German Breast Group,August 2012,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT01638247
Kidney Cancer,NCT00849186,Roswell Park Cancer Institute,August 2007,N/A,Interventional,https://clinicaltrials.gov/show/NCT00849186
Hodgkin Lymphoma,NCT00846742,St. Jude Children's Research Hospital,"June 5, 2009",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00846742
Kidney Cancer,NCT03857373,Nessn Azawi,"February 1, 2019",None,Observational [Patient Registry],https://clinicaltrials.gov/show/NCT03857373
Cholangiocarcinoma,NCT03278106,Mayo Clinic,"October 20, 2017",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT03278106
Cholangiocarcinoma,NCT04521686,"Loxo Oncology, Inc.",October 2020,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT04521686
Uveal Melanoma,NCT00596362,Memorial Sloan Kettering Cancer Center,April 2007,N/A,Interventional,https://clinicaltrials.gov/show/NCT00596362
Mesothelioma,NCT00597116,"Genzyme, a Sanofi Company",December 2007,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00597116
Fallopian Tube Cancer,NCT00753480,"Genentech, Inc.",September 2008,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00753480
Primary Myelofibrosis,NCT01644110,University of Ulm,August 2013,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01644110
Angiosarcoma,NCT02212015,Heidelberg University,July 2014,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02212015
Uveal Melanoma,NCT02936388,"Charite University, Berlin, Germany",January 2016,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT02936388
Plasma Cell Leukemia,NCT01328236,"Clinical Service, China",September 2010,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT01328236
Primary Myelofibrosis,NCT00931762,Novartis Pharmaceuticals,July 2009,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00931762
Male Breast Cancer,NCT00937482,National Cancer Institute (NCI),August 2009,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00937482
Primary Myelofibrosis,NCT00935987,"Sierra Oncology, Inc.",November 2009,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00935987
Kidney Cancer,NCT00002846,Blumenthal Cancer Center at Carolinas Medical Center,September 1995,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00002846
Kidney Cancer,NCT00002589,National Cancer Institute (NCI),July 1994,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00002589
Fallopian Tube Cancer,NCT00002960,Merck Sharp & Dohme Corp.,June 1999,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00002960
Adrenocortical Carcinoma,NCT00002921,Southwest Oncology Group,March 1997,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00002921
Kidney Cancer,NCT00003551,Emory University,August 1998,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00003551
Fallopian Tube Cancer,NCT00003120,Southwest Oncology Group,November 1997,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00003120
Ependymoma,NCT00003479,Burzynski Research Institute,July 1966,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00003479
Kidney Cancer,NCT00003604,Cancer Biotherapy Research Group,October 1997,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00003604
Fallopian Tube Cancer,NCT00002895,Medical Research Council,June 1996,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00002895
Kidney Cancer,NCT00003585,University of New Mexico,August 1996,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00003585
Kidney Cancer,NCT00005995,AEterna Zentaris,October 2000,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00005995
Kidney Cancer,NCT00005056,Cancer Research UK,March 1999,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00005056
Primitive Neuroectodermal Tumor,NCT00003515,Burzynski Research Institute,"December 12, 1996",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00003515
Kidney Cancer,NCT00001238,National Cancer Institute (NCI),"December 5, 1990",None,Observational,https://clinicaltrials.gov/show/NCT00001238
Kidney Cancer,NCT00003656,Weill Medical College of Cornell University,January 1999,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00003656
Cutaneous T Cell Lymphoma,NCT00007345,National Cancer Institute (NCI),"March 8, 2001",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00007345
Fallopian Tube Cancer,NCT00003382,Gynecologic Oncology Group,May 1998,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00003382
Kidney Cancer,NCT00006968,Jonsson Comprehensive Cancer Center,September 2000,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00006968
Fallopian Tube Cancer,NCT00003896,Southwest Oncology Group,September 1999,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00003896
Kidney Cancer,NCT00003584,University of New Mexico,July 1998,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00003584
Hodgkin Lymphoma,NCT00002561,NCIC Clinical Trials Group,"January 25, 1994",Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00002561
Fallopian Tube Cancer,NCT00006391,NYU Langone Health,August 2000,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00006391
Kidney Cancer,NCT00003664,Cancer Biotherapy Research Group,October 1998,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00003664
Kidney Cancer,NCT00006483,Alliance for Clinical Trials in Oncology,October 2000,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00006483
Kidney Cancer,NCT00004244,National Cancer Institute (NCI),March 2000,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00004244
Kidney Cancer,NCT00003928,Case Comprehensive Cancer Center,January 1999,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00003928
Kidney Cancer,NCT00006864,Case Comprehensive Cancer Center,July 2000,Phase 4,Interventional,https://clinicaltrials.gov/show/NCT00006864
Insulinoma,NCT00005910,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),June 2000,N/A,Interventional,https://clinicaltrials.gov/show/NCT00005910
Kidney Cancer,NCT00003683,UNICANCER,March 1998,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00003683
Kidney Cancer,NCT00002611,Children's Oncology Group,July 1995,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00002611
Kidney Cancer,NCT00002733,Hoag Memorial Hospital Presbyterian,January 1996,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00002733
Kidney Cancer,NCT00005816,Duke University,February 2000,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00005816
Kidney Cancer,NCT00005069,Memorial Sloan Kettering Cancer Center,January 2000,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00005069
Fallopian Tube Cancer,NCT00008138,Southwest Oncology Group,March 2001,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00008138
Kidney Cancer,NCT00003542,Memorial Sloan Kettering Cancer Center,May 1998,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00003542
Kidney Cancer,NCT00004880,Jonsson Comprehensive Cancer Center,June 1997,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00004880
Kidney Cancer,NCT00005045,Eastern Cooperative Oncology Group,March 2000,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00005045
Kidney Cancer,NCT00003804,University of Leicester,July 1993,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00003804
Fallopian Tube Cancer,NCT00003358,Memorial Sloan Kettering Cancer Center,January 1998,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00003358
Fallopian Tube Cancer,NCT00002600,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,"October 21, 1994",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00002600
Kidney Cancer,NCT00003968,National Cancer Institute (NCI),June 1999,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00003968
Fallopian Tube Cancer,NCT00004012,Memorial Sloan Kettering Cancer Center,December 1998,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00004012
Fallopian Tube Cancer,NCT00005025,John Stoddard Cancer Center at Iowa Methodist Medical Center,June 2000,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00005025
Kidney Cancer,NCT00005038,The Christie NHS Foundation Trust,June 1999,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00005038
Kidney Cancer,NCT00006255,Case Comprehensive Cancer Center,April 2000,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00006255
Kidney Cancer,NCT00005966,Eastern Cooperative Oncology Group,October 2000,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00005966
Fallopian Tube Cancer,NCT00003636,European Organisation for Research and Treatment of Cancer - EORTC,September 1998,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00003636
Fallopian Tube Cancer,NCT00004064,AltaRex,November 1998,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00004064
Kidney Cancer,NCT00002610,Children's Oncology Group,January 1996,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00002610
Kidney Cancer,NCT00003091,Hoag Memorial Hospital Presbyterian,January 1996,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00003091
Male Breast Cancer,NCT00005817,National Cancer Institute (NCI),March 2000,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00005817
T-cell Lymphoma,NCT00001582,National Cancer Institute (NCI),"June 7, 1997",None,Observational,https://clinicaltrials.gov/show/NCT00001582
Fallopian Tube Cancer,NCT00003064,Herbert Irving Comprehensive Cancer Center,January 1997,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00003064
Kidney Cancer,NCT00002466,Memorial Sloan Kettering Cancer Center,May 1990,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00002466
Fallopian Tube Cancer,NCT00006942,National Cancer Institute (NCI),October 2000,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00006942
Fallopian Tube Cancer,NCT00003160,Theradex,September 1997,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00003160
Kidney Cancer,NCT00002737,European Organisation for Research and Treatment of Cancer - EORTC,March 1996,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00002737
Fallopian Tube Cancer,NCT00004934,Nordic Society for Gynaecologic Oncology,August 1999,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00004934
Fallopian Tube Cancer,NCT00006041,Memorial Sloan Kettering Cancer Center,February 2000,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00006041
Kidney Cancer,NCT00003181,"Hope Cancer Institute, Inc.",May 1997,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00003181
Fallopian Tube Cancer,NCT00003380,Gynecologic Oncology Group,May 1998,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00003380
Kidney Cancer,NCT00004135,University of Chicago,February 1999,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00004135
Kidney Cancer,NCT00002847,Blumenthal Cancer Center at Carolinas Medical Center,September 1995,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00002847
Fallopian Tube Cancer,NCT00004060,"Daiichi Sankyo, Inc.",July 1999,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00004060
Chondrosarcoma,NCT00003292,Southwest Oncology Group,July 1998,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00003292
Kidney Cancer,NCT00003102,Ludwig Institute for Cancer Research,July 1997,Phase 1/Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00003102
Fallopian Tube Cancer,NCT00003944,Fox Chase Cancer Center,August 1998,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00003944
Kidney Cancer,NCT00003126,Loyola University,June 1997,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00003126
Fallopian Tube Cancer,NCT00006235,Gynecologic Oncology Group,None,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00006235
Fallopian Tube Cancer,NCT00003385,Gynecologic Oncology Group,March 1999,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00003385
Kidney Cancer,NCT00003308,Eastern Cooperative Oncology Group,July 1998,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00003308
Adrenocortical Carcinoma,NCT00003038,Mayo Clinic,October 1997,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00003038
Kidney Cancer,NCT00003390,Memorial Sloan Kettering Cancer Center,June 1998,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00003390
Fallopian Tube Cancer,NCT00002538,Gynecologic Oncology Group,September 1993,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00002538
Kidney Cancer,NCT00006384,City of Hope Medical Center,November 2000,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00006384
Pheochromocytoma,NCT00001229,"National Heart, Lung, and Blood Institute (NHLBI)",October 1988,None,Observational,https://clinicaltrials.gov/show/NCT00001229
Kidney Cancer,NCT00002473,European Organisation for Research and Treatment of Cancer - EORTC,March 1992,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00002473
Adrenocortical Carcinoma,NCT00002608,Ottawa Regional Cancer Centre,May 1994,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00002608
Fallopian Tube Cancer,NCT00003345,Memorial Sloan Kettering Cancer Center,October 1997,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00003345
Fallopian Tube Cancer,NCT00003967,Gynecologic Oncology Group,September 1999,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00003967
Kidney Cancer,NCT00005027,Barbara Ann Karmanos Cancer Institute,June 2000,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00005027
Kidney Cancer,NCT00003553,"National Heart, Lung, and Blood Institute (NHLBI)","February 9, 1998",Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00003553
Kidney Cancer,NCT00006022,Virginia Commonwealth University,September 2000,Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00006022
Pheochromocytoma,NCT00004847,Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),"March 22, 2000",Phase 1,Interventional,https://clinicaltrials.gov/show/NCT00004847
Kidney Cancer,NCT00003914,Mayo Clinic,August 1999,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00003914
Fallopian Tube Cancer,NCT00005645,"Genzyme, a Sanofi Company",May 1999,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00005645
Fallopian Tube Cancer,NCT00006454,AGO Study Group,December 1999,Phase 3,Interventional,https://clinicaltrials.gov/show/NCT00006454
Fallopian Tube Cancer,NCT00003634,AltaRex,April 1998,Phase 2,Interventional,https://clinicaltrials.gov/show/NCT00003634
